Podcasts about marketed

Study and process of soliciting customers

  • 286PODCASTS
  • 449EPISODES
  • 38mAVG DURATION
  • 1EPISODE EVERY OTHER WEEK
  • May 5, 2025LATEST
marketed

POPULARITY

20172018201920202021202220232024


Best podcasts about marketed

Latest podcast episodes about marketed

Dr. Joseph Mercola - Take Control of Your Health
The Health Reset: Ancient Wisdom for Modern Wellness - AI Podcast

Dr. Joseph Mercola - Take Control of Your Health

Play Episode Listen Later May 5, 2025 9:58


Story at-a-glance Chronic disease is at an all-time high — Modern lifestyle shifts have fueled skyrocketing rates of diabetes, heart disease, obesity and autoimmune disorders Vegetable oils have replaced natural fats — Marketed as a healthier alternative, seed oils high in linoleic acid have contributed to inflammation, mitochondrial dysfunction and metabolic disease Endocrine-disrupting chemicals (EDCs) are everywhere — Found in plastics, pesticides and personal care products, EDCs interfere with hormone function, impacting fertility, thyroid health and cancer risk Lifestyle factors are driving mitochondrial decline — Inactivity, poor diet and lack of sunlight exposure have disrupted natural metabolic processes, which led to energy deficits and chronic fatigue Traditional lifestyles offer a blueprint for better health — Whole foods, natural movement and circadian alignment support mitochondrial function and cellular repair, and reverse modern health declines

International Tax Bites
Episode 85.. Part 2 of closing in on promoters of marketed tax avoidance

International Tax Bites

Play Episode Listen Later Apr 17, 2025 36:59


In the Spring Statement the Chancellor announced a consultation on reforming the rules around marketed tax avoidance schemes. In this two Part Bonus Episode Harriet and Grahame take a deep dive into the consultation documents.

International Tax Bites
Episode 84 Part 1 of closing in on promoters of marketed tax avoidance

International Tax Bites

Play Episode Listen Later Apr 13, 2025 74:23


In the Spring Statement the Chancellor announced a consultation on reforming the rules around marketed tax avoidance schemes. In this two Part Bonus Episode Harriet and Grahame take a deep dive into the consultation documents.

Make Music Income
EP141. How I Produced, Released, and Marketed My Newest Single!

Make Music Income

Play Episode Listen Later Apr 7, 2025 49:31


This episode celebrates the release of “The Windmills of My Mind”, the newest release by Player A Jazz.So in this podcast, I breakdown how I produced it, released it (and the drama surrounding that), and how I am marketing it to the world.LINKS IN THIS VIDEO:HEAR THE NEW SINGLE:https://distrokid.com/hyperfollow/playera/the-windmills-of-your-mind(You can REALLY help by streaming the song ALL THE WAY THROUGH on your favorite streaming service, SAVING the single in Spotify, or SHARING the Hyperfollow link above on your socials!)MUSIC RELEASE CELEBRATION SALE:ONE-ON-ONE MUSIC CAREER COACHING FOR COMPOSERS AND PRODUCERS: 25% Off $75!Get Feedback From Eric on Your Music & Career:https://makemusicincome.com/coaching/// GET YOUR MUSIC TO TV, FILM, ADS, AND GAMING: (Start the Course for FREE!)https://payhip.com/b/KtoqHSALE PRICE: $49!// SELL YOUR MUSIC ON NON-EXCLUSIVE STOCK LIBRARIES (Start the course for FREE!)https://payhip.com/b/pvsfLNOW JUST $49!GET BOTH COURSES for just $75!https://payhip.com/b/U7ITAFREE EBOOK: THE DO-EVERYTHING CHECKLIST FOR YOUR SONGShttps://makemusicincome.com/checklistDISTROKID: Get your music to Spotify, Apple, Youtube, and more for one yearly price.Get 7% Off:https://distrokid.com/vip/seven/911910Get 50% off if you are a student or educator!https://distrokid.com/student/911910BECOME A POSITIVE SPIN SONGS PARTNERWork directly with composer and producer Eric Copeland to develop albums of music for pitching to sync licensing for TV, Film, Ads, and Gaming.https://positivespinsongs.com/partnersintro/MY SYNC LICENSING MUSICPositive Spin Songs - https://positivespinsongs.comMY PERSONAL MUSIC:https://www.ericcopelandmusic.comGet FREE stuff athttps://makemusicincome.com/free/// GET YOUR MUSIC TO TV, FILM, ADS, AND GAMING: (Start the Course for FREE!)https://payhip.com/b/KtoqH// SELL YOUR MUSIC ON NON-EXCLUSIVE STOCK LIBRARIES (Start the course for FREE!)https://payhip.com/b/pvsfLNOW JUST $49!FREE EBOOK: THE DO-EVERYTHING CHECKLIST FOR YOUR SONGShttps://makemusicincome.com/checklistFREE COURSE: HOW TO UPLOAD TO POND5https://makemusicincome.com/pond5FREE EBOOK: 50 WAYS TO MAKE MUSIC INCOME V4https://makemusicincome.com/50waysFREE EBOOK!: TOOLS YOU NEED TO MAKE MUSIC INCOME V2https://makemusicincome.com/toolsFREE STOCK MUSIC RESEARCH PAPER: "The Ubiquitous Style, Form, and Instrumentation of Corporate Stock Music"https://makemusicincome.com/ubiquitousJOIN OUR EMAIL LIST (Get an email when we release new videos!)http://eepurl.com/hF8ihrTHE OFFICIAL WEB SITE:https://makemusicincome.com/OUR WEEKLY PODCAST:https://anchor.fm/makemusicincomeNEED GEAR?SWEETWATER SOUND: Support the channel by using this link to find the latest deals and get the gear you need at our favorite music store, Sweetwater Sound!https://sweetwater.sjv.io/q4JEB5DISCO: Show off your amazing portfolio and be where the music supervisors and music buyers are!https://disco.ac/signup?b=2095&u=34391IDENTIFYY: Get paid when your music is used on YouTubehttps://identifyy.com?referral=MTMzMjc2POND5: Get into Music Licensing easily! Use this referral code to sign up and get started selling YOUR music with Pond5!https://www.pond5.com?ref=FromtheMomentMusicJOIN OUR COMMUNITY ON DISCORD:https://bit.ly/3fYDSVdTimestamps:0:00 - The Big Day!5:25 - Music Release Sale-abration!8:13 - Eric's Pre-Release Week12:33 - The News: Duh!14:48 - Production21:44 - Release (CDBaby vs. DistroKid)33:40 - Marketing

Mint Techcetra
How DeepSeek, Manus are rocking OpenAI's boat

Mint Techcetra

Play Episode Listen Later Mar 19, 2025 28:51


Is Manus the AI that will finally think like us, or just another digital dream?" The world's first general AI agent, created by a major disruptor, is forcing us to rethink what we expect from artificial intelligence. this AI agent isn't just another tool; it's a leap towards truly general AI. But with this kind of power, the question remains: are we ready for an AI that can think and adapt like a human? There's excitement, but also skepticism about what this means for the future of AI and its role in our lives. Starlink has entered the Indian market through partnerships with Airtel and Reliance Jio, and it's shaking things up. Though satellite internet can connect remote areas, the real concern is whether it will be affordable for the masses. With a hefty upfront cost for the hardware, the big question is if it can really reach the people who need it most—those in rural, underserved regions. Apple's new iPhone 16E has people talking. Marketed as a budget option, it's a tempting choice for those wanting to try out the iPhone experience without breaking the bank. But when you look at the price and what it offers—or doesn't offer—it raises the question: does this really live up to the “budget” label, or is it just another compromise for the Apple fanbase?

Drivetime with DeRusha
Should we think of schools as "brands" to be marketed?

Drivetime with DeRusha

Play Episode Listen Later Mar 17, 2025 10:00


Jason talks with Nick Leroy from SchoolMint about working with some St. Paul schools and helping increasing enrollment through marketing strategies.

WWL First News with Tommy Tucker
New Orleans is being marketed in a unique...and musical...way

WWL First News with Tommy Tucker

Play Episode Listen Later Mar 6, 2025 10:45


New Orleans and Company came up with a new and unique way of marketing the city. We talk with Walt Leger, the president and CEO, about their new plan.

The Gary Null Show
The Gary Null Show 3.4.25

The Gary Null Show

Play Episode Listen Later Mar 4, 2025 58:09


Dr. Gary Null provides a commentary on "Universal  Healthcare"       Universal Healthcare is the Solution to a Broken Medical System Gary Null, PhD Progressive Radio Network, March 3, 2025 For over 50 years, there has been no concerted or successful effort to bring down medical costs in the American healthcare system. Nor are the federal health agencies making disease prevention a priority. Regardless whether the political left or right sponsors proposals for reform, such measures are repeatedly defeated by both parties in Congress. As a result, the nation's healthcare system remains one of the most expensive and least efficient in the developed world. For the past 30 years, medical bills contributing to personal debt regularly rank among the top three causes of personal bankruptcy. This is a reality that reflects not only the financial strain on ordinary Americans but the systemic failure of the healthcare system itself. The urgent question is: If President Trump and his administration are truly seeking to reduce the nation's $36 trillion deficit, why is there no serious effort to reform the most bloated and corrupt sector of the economy? A key obstacle is the widespread misinformation campaign that falsely claims universal health care would cost an additional $2 trillion annually and further balloon the national debt. However, a more honest assessment reveals the opposite. If the US adopted a universal single-payer system, the nation could actually save up to $20 trillion over the next 10 years rather than add to the deficit. Even with the most ambitious efforts by people like Elon Musk to rein in federal spending or optimize government efficiency, the estimated savings would only amount to $500 billion. This is only a fraction of what could be achieved through comprehensive healthcare reform alone. Healthcare is the largest single expenditure of the federal budget. A careful examination of where the $5 trillion spent annually on healthcare actually goes reveals massive systemic fraud and inefficiency. Aside from emergency medicine, which accounts for only 10-12 percent of total healthcare expenditures, the bulk of this spending does not deliver better health outcomes nor reduce trends in physical and mental illness. Applying Ockham's Razor, the principle that the simplest solution is often the best, the obvious conclusion is that America's astronomical healthcare costs are the direct result of price gouging on an unimaginable scale. For example, in most small businesses, profit margins range between 1.6 and 2.5 percent, such as in grocery retail. Yet the pharmaceutical industrial complex routinely operates on markup rates as high as 150,000 percent for many prescription drugs. The chart below highlights the astronomical gap between the retail price of some top-selling patented pharmaceutical medications and their generic equivalents. Drug Condition Patent Price (per unit) Generic Price Estimated Manufacture Cost Markup Source Insulin (Humalog) Diabetes $300 $30 $3 10,000% Rand (2021) EpiPen Allergic reactions $600 $30 $10 6,000% BMJ (2022) Daraprim Toxoplasmosis $750/pill $2 $0.50 150,000% JAMA (2019) Harvoni Hepatitis C $94,500 (12 weeks) $30,000 $200 47,000% WHO Report (2018) Lipitor Cholesterol $150 $10 $0.50 29,900% Health Affairs (2020) Xarelto Blood Thinner $450 $25 $1.50 30,000% NEJM (2020) Abilify Schizophrenia $800 (30 tablets) $15 $2 39,900% AJMC (2019) Revlimid Cancer $16,000/mo $450 $150 10,500% Kaiser Health News (2021) Humira Arthritis $2,984/dose $400 $50 5,868% Rand (2021) Sovaldi Hepatitis C $1,000/pill $10 $2 49,900% JAMA (2021) Xolair Asthma $2,400/dose $300 $50 4,800% NEJM (2020) Gleevec Leukemia $10,000/mo $350 $200 4,900% Harvard Public Health Review (2020) OxyContin Pain Relief $600 (30 tablets) $15 $0.50 119,900% BMJ (2022) Remdesivir Covid-19 $3,120 (5 doses) N/A $10 31,100% The Lancet (2020) The corruption extends far beyond price gouging. Many pharmaceutical companies convince federal health agencies to fund their basic research and drug development with taxpayer dollars. Yet when these companies bring successful products to market, the profits are kept entirely by the corporations or shared with the agencies or groups of government scientists. On the other hand, the public, who funded the research, receives no financial return. This amounts to a systemic betrayal of the public trust on a scale of hundreds of billions of dollars annually. Another significant contributor to rising healthcare costs is the widespread practice of defensive medicine that is driven by the constant threat of litigation. Over the past 40 years, defensive medicine has become a cottage industry. Physicians order excessive diagnostic tests and unnecessary treatments simply to protect themselves from lawsuits. Study after study has shown that these over-performed procedures not only inflate costs but lead to iatrogenesis or medical injury and death caused by the medical  system and practices itself. The solution is simple: adopting no-fault healthcare coverage for everyone where patients receive care without needing to sue and thereby freeing doctors from the burden of excessive malpractice insurance. A single-payer universal healthcare system could fundamentally transform the entire industry by capping profits at every level — from drug manufacturers to hospitals to medical equipment suppliers. The Department of Health and Human Services would have the authority to set profit margins for medical procedures. This would ensure that healthcare is determined by outcomes, not profits. Additionally, the growing influence of private equity firms and vulture capitalists buying up hospitals and medical clinics across America must be reined in. These equity firms prioritize profit extraction over improving the quality of care. They often slash staff, raise prices, and dictate medical procedures based on what will yield the highest returns. Another vital reform would be to provide free medical education for doctors and nurses in exchange for five years of service under the universal system. Medical professionals would earn a realistic salary cap to prevent them from being lured into equity partnerships or charging exorbitant rates. The biggest single expense in the current system, however, is the private health insurance industry, which consumes 33 percent of the $5 trillion healthcare budget. Health insurance CEOs consistently rank among the highest-paid executives in the country. Their companies, who are nothing more than bean counters, decide what procedures and drugs will be covered, partially covered, or denied altogether. This entire industry is designed to place profits above patients' lives. If the US dismantled its existing insurance-based system and replaced it with a fully reformed national healthcare model, the country could save $2.7 trillion annually while simultaneously improving health outcomes. Over the course of 10 years, those savings would amount to $27 trillion. This could wipe out nearly the entire national debt in a short time. This solution has been available for decades but has been systematically blocked by corporate lobbying and bipartisan corruption in Washington. The path forward is clear but only if American citizens demand a system where healthcare is valued as a public service and not a commodity. The national healthcare crisis is not just a fiscal issue. It is a crucial moral failure of the highest order. With the right reforms, the nation could simultaneously restore its financial health and deliver the kind of healthcare system its citizens have long deserved. American Healthcare: Corrupt, Broken and Lethal Richard Gale and Gary Null Progressive Radio Network, March 3, 2025 For a nation that prides itself on being the world's wealthiest, most innovative and technologically advanced, the US' healthcare system is nothing less than a disaster and disgrace. Not only are Americans the least healthy among the most developed nations, but the US' health system ranks dead last among high-income countries. Despite rising costs and our unshakeable faith in American medical exceptionalism, average life expectancy in the US has remained lower than other OECD nations for many years and continues to decline. The United Nations recognizes healthcare as a human right. In 2018, former UN Secretary General Ban Ki-moon denounced the American healthcare system as "politically and morally wrong." During the pandemic it is estimated that two to three years was lost on average life expectancy. On the other hand, before the Covid-19 pandemic, countries with universal healthcare coverage found their average life expectancy stable or slowly increasing. The fundamental problem in the U.S. is that politics have been far too beholden to the pharmaceutical, HMO and private insurance industries. Neither party has made any concerted effort to reign in the corruption of corporate campaign funding and do what is sensible, financially feasible and morally correct to improve Americans' quality of health and well-being.   The fact that our healthcare system is horribly broken is proof that moneyed interests have become so powerful to keep single-payer debate out of the media spotlight and censored. Poll after poll shows that the American public favors the expansion of public health coverage. Other incremental proposals, including Medicare and Medicaid buy-in plans, are also widely preferred to the Affordable Care Act or Obamacare mess we are currently stuck with.   It is not difficult to understand how the dismal state of American medicine is the result of a system that has been sold out to the free-market and the bottom line interests of drug makers and an inflated private insurance industry. How advanced and ethically sound can a healthcare system be if tens of millions of people have no access to medical care because it is financially out of their reach?  The figures speak for themselves. The U.S. is burdened with a $41 trillion Medicare liability. The number of uninsured has declined during the past several years but still lingers around 25 million. An additional 30-35 million are underinsured. There are currently 65 million Medicare enrollees and 89 million Medicaid recipients. This is an extremely unhealthy snapshot of the country's ability to provide affordable healthcare and it is certainly unsustainable. The system is a public economic failure, benefiting no one except the large and increasingly consolidated insurance and pharmaceutical firms at the top that supervise the racket.   Our political parties have wrestled with single-payer or universal healthcare for decades. Obama ran his first 2008 presidential campaign on a single-payer platform. Since 1985, his campaign health adviser, the late Dr. Quentin Young from the University of Illinois Medical School, was one of the nation's leading voices calling for universal health coverage.  During a private conversation with Dr. Young shortly before his passing in 2016, he conveyed his sense of betrayal at the hands of the Obama administration. Dr. Young was in his 80s when he joined the Obama campaign team to help lead the young Senator to victory on a promise that America would finally catch up with other nations. The doctor sounded defeated. He shared how he was manipulated, and that Obama held no sincere intention to make universal healthcare a part of his administration's agenda. During the closed-door negotiations, which spawned the weak and compromised Affordable Care Act, Dr. Young was neither consulted nor invited to participate. In fact, he told us that he never heard from Obama again after his White House victory.   Past efforts to even raise the issue have been viciously attacked. A huge army of private interests is determined to keep the public enslaved to private insurers and high medical costs. The failure of our healthcare is in no small measure due to it being a fully for-profit operation. Last year, private health insurance accounted for 65 percent of coverage. Consider that there are over 900 private insurance companies in the US. National Health Expenditures (NHE) grew to $4.5 trillion in 2022, which was 17.3 percent of GDP. Older corporate rank-and-file Democrats and Republicans argue that a single-payer or socialized medical program is unaffordable. However, not only is single-payer affordable, it will end bankruptcies due to unpayable medical debt. In addition, universal healthcare, structured on a preventative model, will reduce disease rates at the outset.    Corporate Democrats argue that Obama's Affordable Care Act (ACA) was a positive step inching the country towards complete public coverage. However, aside from providing coverage to the poorest of Americans, Obamacare turned into another financial anchor around the necks of millions more. According to the health policy research group KFF, the average annual health insurance premium for single coverage is $8,400 and almost $24,000 for a family. In addition, patient out-of-pocket costs continue to increase, a 6.6% increase to $471 billion in 2022. Rather than healthcare spending falling, it has exploded, and the Trump and Biden administrations made matters worse.    Clearly, a universal healthcare program will require flipping the script on the entire private insurance industry, which employed over half a million people last year.  Obviously, the most volatile debate concerning a national universal healthcare system concerns cost. Although there is already a socialized healthcare system in place -- every federal legislator, bureaucrat, government employee and veteran benefits from it -- fiscal Republican conservatives and groups such as the Koch Brothers network are single-mindedly dedicated to preventing the expansion of Medicare and Medicaid. A Koch-funded Mercatus analysis made the outrageous claim that a single-payer system would increase federal health spending by $32 trillion in ten years. However, analyses and reviews by the Congressional Budget Office in the early 1990s concluded that such a system would only increase spending at the start; enormous savings would quickly offset it as the years pass. In one analysis, "the savings in administrative costs [10 percent of health spending] would be more than enough to offset the expense of universal coverage."    Defenders of those advocating for funding a National Health Program argue this can primarily be accomplished by raising taxes to levels comparable to other developed nations. This was a platform Senator Bernie Sanders and some of the younger progressive Democrats in the House campaigned on. The strategy was to tax the highest multimillion-dollar earners 60-70 percent. Despite the outrage of its critics, including old rank-and-file multi-millionaire Democrats like Nancy Pelosi and Chuck Schumer, this is still far less than in the past. During the Korean War, the top tax rate was 91 percent; it declined to 70 percent in the late 1960s. Throughout most of the 1970s, those in the lowest income bracket were taxed at 14 percent. We are not advocating for this strategy because it ignores where the funding is going, and the corruption in the system that is contributing to exorbitant waste.    But Democratic supporters of the ACA who oppose a universal healthcare plan ignore the additional taxes Obama levied to pay for the program. These included surtaxes on investment income, Medicare taxes from those earning over $200,000, taxes on tanning services, an excise tax on medical equipment, and a 40 percent tax on health coverage for costs over the designated cap that applied to flexible savings and health savings accounts. The entire ACA was reckless, sloppy and unnecessarily complicated from the start.    The fact that Obamacare further strengthened the distinctions between two parallel systems -- federal and private -- with entirely different economic structures created a labyrinth of red tape, rules, and wasteful bureaucracy. Since the ACA went into effect, over 150 new boards, agencies and programs have had to be established to monitor its 2,700 pages of gibberish. A federal single-payer system would easily eliminate this bureaucracy and waste.    A medical New Deal to establish universal healthcare coverage is a decisive step in the correct direction. But we must look at the crisis holistically and in a systematic way. Simply shuffling private insurance into a federal Medicare-for-all or buy-in program, funded by taxing the wealthiest of citizens, would only temporarily reduce costs. It will neither curtail nor slash escalating disease rates e. Any effective healthcare reform must also tackle the underlying reasons for Americans' poor state of health. We cannot shy away from examining the social illnesses infecting our entire free-market capitalist culture and its addiction to deregulation. A viable healthcare model would have to structurally transform how the medical economy operates. Finally, a successful medical New Deal must honestly evaluate the best and most reliable scientific evidence in order to effectively redirect public health spending.    For example, Dr. Ezekiel Emanuel, a former Obama healthcare adviser, observed that AIDS-HIV measures consume the most public health spending, even though the disease "ranked 75th on the list of diseases by personal health expenditures." On the other hand, according to the American Medical Association, a large percentage of the nation's $3.4 trillion healthcare spending goes towards treating preventable diseases, notably diabetes, common forms of heart disease, and back and neck pain conditions. In 2016, these three conditions were the most costly and accounted for approximately $277 billion in spending. Last year, the CDC announced the autism rate is now 1 in 36 children compared to 1 in 44 two years ago. A retracted study by Mark Blaxill, an autism activist at the Holland Center and a friend of the authors, estimates that ASD costs will reach $589 billion annually by 2030. There are no signs that this alarming trend will reverse and decline; and yet, our entire federal health system has failed to conscientiously investigate the underlying causes of this epidemic. All explanations that might interfere with the pharmaceutical industry's unchecked growth, such as over-vaccination, are ignored and viciously discredited without any sound scientific evidence. Therefore, a proper medical New Deal will require a systemic overhaul and reform of our federal health agencies, especially the HHS, CDC and FDA. Only the Robert Kennedy Jr presidential campaign is even addressing the crisis and has an inexpensive and comprehensive plan to deal with it. For any medical revolution to succeed in advancing universal healthcare, the plan must prioritize spending in a manner that serves public health and not private interests. It will also require reshuffling private corporate interests and their lobbyists to the sidelines, away from any strategic planning, in order to break up the private interests' control over federal agencies and its revolving door policies. Aside from those who benefit from this medical corruption, the overwhelming majority of Americans would agree with this criticism. However, there is a complete lack of national trust that our legislators, including the so-called progressives, would be willing to undertake such actions.    In addition, America's healthcare system ignores the single most critical initiative to reduce costs - that is, preventative efforts and programs instead of deregulation and closing loopholes designed to protect the drug and insurance industries' bottom line. Prevention can begin with banning toxic chemicals that are proven health hazards associated with current disease epidemics, and it can begin by removing a 1,000-plus toxins already banned in Europe. This should be a no-brainer for any legislator who cares for public health. For example, Stacy Malkan, co-founder of the Campaign for Safe Cosmetics, notes that "the policy approach in the US and Europe is dramatically different" when it comes to chemical allowances in cosmetic products. Whereas the EU has banned 1,328 toxic substances from the cosmetic industry alone, the US has banned only 11. The US continues to allow carcinogenic formaldehyde, petroleum, forever chemicals, many parabens (an estrogen mimicker and endocrine hormone destroyer), the highly allergenic p-phenylenediamine or PBD, triclosan, which has been associated with the rise in antibiotic resistant bacteria, avobenzone, and many others to be used in cosmetics, sunscreens, shampoo and hair dyes.   Next, the food Americans consume can be reevaluated for its health benefits. There should be no hesitation to tax the unhealthiest foods, such as commercial junk food, sodas and candy relying on high fructose corn syrup, products that contain ingredients proven to be toxic, and meat products laden with dangerous chemicals including growth hormones and antibiotics. The scientific evidence that the average American diet is contributing to rising disease trends is indisputable. We could also implement additional taxes on the public advertising of these demonstrably unhealthy products. All such tax revenue would accrue to a national universal health program to offset medical expenditures associated with the very illnesses linked to these products. Although such tax measures would help pay for a new medical New Deal, it may be combined with programs to educate the public about healthy nutrition if it is to produce a reduction in the most common preventable diseases. In fact, comprehensive nutrition courses in medical schools should be mandatory because the average physician receives no education in this crucial subject.  In addition, preventative health education should be mandatory throughout public school systems.   Private insurers force hospitals, clinics and private physicians into financial corners, and this is contributing to prodigious waste in money and resources. Annually, healthcare spending towards medical liability insurance costs tens of billions of dollars. In particular, this economic burden has taxed small clinics and physicians. It is well past the time that physician liability insurance is replaced with no-fault options. Today's doctors are spending an inordinate amount of money to protect themselves. Legions of liability and trial lawyers seek big paydays for themselves stemming from physician error. This has created a culture of fear among doctors and hospitals, resulting in the overly cautious practice of defensive medicine, driving up costs and insurance premiums just to avoid lawsuits. Doctors are forced to order unnecessary tests and prescribe more medications and medical procedures just to cover their backsides. No-fault insurance is a common-sense plan that enables physicians to pursue their profession in a manner that will reduce iatrogenic injuries and costs. Individual cases requiring additional medical intervention and loss of income would still be compensated. This would generate huge savings.    No other nation suffers from the scourge of excessive drug price gouging like the US. After many years of haggling to lower prices and increase access to generic drugs, only a minute amount of progress has been made in recent years. A 60 Minutes feature about the Affordable Care Act reported an "orgy of lobbying and backroom deals in which just about everyone with a stake in the $3-trillion-a-year health industry came out ahead—except the taxpayers.” For example, Life Extension magazine reported that an antiviral cream (acyclovir), which had lost its patent protection, "was being sold to pharmacies for 7,500% over the active ingredient cost. The active ingredient (acyclovir) costs only 8 pennies, yet pharmacies are paying a generic maker $600 for this drug and selling it to consumers for around $700." Other examples include the antibiotic Doxycycline. The price per pill averages 7 cents to $3.36 but has a 5,300 percent markup when it reaches the consumer. The antidepressant Clomipramine is marked up 3,780 percent, and the anti-hypertensive drug Captopril's mark-up is 2,850 percent. And these are generic drugs!    Medication costs need to be dramatically cut to allow drug manufacturers a reasonable but not obscene profit margin. By capping profits approximately 100 percent above all costs, we would save our system hundreds of billions of dollars. Such a measure would also extirpate the growing corporate misdemeanors of pricing fraud, which forces patients to pay out-of-pocket in order to make up for the costs insurers are unwilling to pay.    Finally, we can acknowledge that our healthcare is fundamentally a despotic rationing system based upon high insurance costs vis-a-vis a toss of the dice to determine where a person sits on the economic ladder. For the past three decades it has contributed to inequality. The present insurance-based economic metrics cast millions of Americans out of coverage because private insurance costs are beyond their means. Uwe Reinhardt, a Princeton University political economist, has called our system "brutal" because it "rations [people] out of the system." He defined rationing as "withholding something from someone that is beneficial." Discriminatory healthcare rationing now affects upwards to 60 million people who have been either priced out of the system or under insured. They make too much to qualify for Medicare under Obamacare, yet earn far too little to afford private insurance costs and premiums. In the final analysis, the entire system is discriminatory and predatory.    However, we must be realistic. Almost every member of Congress has benefited from Big Pharma and private insurance lobbyists. The only way to begin to bring our healthcare program up to the level of a truly developed nation is to remove the drug industry's rampant and unnecessary profiteering from the equation.     How did Fauci memory-hole a cure for AIDS and get away with it?   By Helen Buyniski   Over 700,000 Americans have died of AIDS since 1981, with the disease claiming some 42.3 million victims worldwide. While an HIV diagnosis is no longer considered a certain death sentence, the disease looms large in the public imagination and in public health funding, with contemporary treatments running into thousands of dollars per patient annually.   But was there a cure for AIDS all this time - an affordable and safe treatment that was ruthlessly suppressed and attacked by the US public health bureaucracy and its agents? Could this have saved millions of lives and billions of dollars spent on AZT, ddI and failed HIV vaccine trials? What could possibly justify the decision to disappear a safe and effective approach down the memory hole?   The inventor of the cure, Gary Null, already had several decades of experience creating healing protocols for physicians to help patients not responding well to conventional treatments by the time AIDS was officially defined in 1981. Null, a registered dietitian and board-certified nutritionist with a PhD in human nutrition and public health science, was a senior research fellow and Director of Anti-Aging Medicine at the Institute of Applied Biology for 36 years and has published over 950 papers, conducting groundbreaking experiments in reversing biological aging as confirmed with DNA methylation testing. Additionally, Null is a multi-award-winning documentary filmmaker, bestselling author, and investigative journalist whose work exposing crimes against humanity over the last 50 years has highlighted abuses by Big Pharma, the military-industrial complex, the financial industry, and the permanent government stay-behind networks that have come to be known as the Deep State.   Null was contacted in 1974 by Dr. Stephen Caiazza, a physician working with a subculture of gay men in New York living the so-called “fast track” lifestyle, an extreme manifestation of the gay liberation movement that began with the Stonewall riots. Defined by rampant sexual promiscuity and copious use of illegal and prescription drugs, including heavy antibiotic use for a cornucopia of sexually-transmitted diseases, the fast-track never included more than about two percent of gay men, though these dominated many of the bathhouses and clubs that defined gay nightlife in the era. These patients had become seriously ill as a result of their indulgence, generally arriving at the clinic with multiple STDs including cytomegalovirus and several types of herpes and hepatitis, along with candida overgrowth, nutritional deficiencies, gut issues, and recurring pneumonia. Every week for the next 10 years, Null would counsel two or three of these men - a total of 800 patients - on how to detoxify their bodies and de-stress their lives, tracking their progress with Caiazza and the other providers at weekly feedback meetings that he credits with allowing the team to quickly evaluate which treatments were most effective. He observed that it only took about two years on the “fast track” for a healthy young person to begin seeing muscle loss and the recurrent, lingering opportunistic infections that would later come to be associated with AIDS - while those willing to commit to a healthier lifestyle could regain their health in about a year.    It was with this background that Null established the Tri-State Healing Center in Manhattan in 1980, staffing the facility with what would eventually run to 22 certified health professionals to offer safe, natural, and effective low- and no-cost treatments to thousands of patients with HIV and AIDS-defining conditions. Null and his staff used variations of the protocols he had perfected with Caiazza's patients, a multifactorial patient-tailored approach that included high-dose vitamin C drips, intravenous ozone therapy, juicing and nutritional improvements and supplementation, aspects of homeopathy and naturopathy with some Traditional Chinese Medicine and Ayurvedic practices. Additional services offered on-site included acupuncture and holistic dentistry, while peer support groups were also held at the facility so that patients could find community and a positive environment, healing their minds and spirits while they healed their bodies.   “Instead of trying to kill the virus with antiretroviral pharmaceuticals designed to stop viral replication before it kills patients, we focused on what benefits could be gained by building up the patients' natural immunity and restoring biochemical integrity so the body could fight for itself,” Null wrote in a 2014 article describing the philosophy behind the Center's approach, which was wholly at odds with the pharmaceutical model.1   Patients were comprehensively tested every week, with any “recovery” defined solely by the labs, which documented AIDS patient after patient - 1,200 of them - returning to good health and reversing their debilitating conditions. Null claims to have never lost an AIDS patient in the Center's care, even as the death toll for the disease - and its pharmaceutical standard of care AZT - reached an all-time high in the early 1990s. Eight patients who had opted for a more intensive course of treatment - visiting the Center six days a week rather than one - actually sero-deconverted, with repeated subsequent testing showing no trace of HIV in their bodies.   As an experienced clinical researcher himself, Null recognized that any claims made by the Center would be massively scrutinized, challenging as they did the prevailing scientific consensus that AIDS was an incurable, terminal illness. He freely gave his protocols to any medical practitioner who asked, understanding that his own work could be considered scientifically valid only if others could replicate it under the same conditions. After weeks of daily observational visits to the Center, Dr. Robert Cathcart took the protocols back to San Francisco, where he excitedly reported that patients were no longer dying in his care.    Null's own colleague at the Institute of Applied Biology, senior research fellow Elana Avram, set up IV drip rooms at the Institute and used his intensive protocols to sero-deconvert 10 patients over a two-year period. While the experiment had been conducted in secret, as the Institute had been funded by Big Pharma since its inception half a century earlier, Avram had hoped she would be able to publish a journal article to further publicize Null's protocols and potentially help AIDS patients, who were still dying at incredibly high rates thanks to Burroughs Wellcome's noxious but profitable AZT. But as she would later explain in a 2019 letter to Null, their groundbreaking research never made it into print - despite meticulous documentation of their successes - because the Institute's director and board feared their pharmaceutical benefactors would withdraw the funding on which they depended, given that Null's protocols did not involve any patentable or otherwise profitable drugs. When Avram approached them about publication, the board vetoed the idea, arguing that it would “draw negative attention because [the work] was contrary to standard drug treatments.” With no real point in continuing experiments along those lines without institutional support and no hope of obtaining funding from elsewhere, the department she had created specifically for these experiments shut down after a two-year followup with her test subjects - all of whom remained alive and healthy - was completed.2   While the Center was receiving regular visits by this time from medical professionals and, increasingly, black celebrities like Stokely Carmichael and Isaac Hayes, who would occasionally perform for the patients, the news was spreading by word of mouth alone - not a single media outlet had dared to document the clinic that was curing AIDS patients for free. Instead, they gave airtime to Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases, who had for years been spreading baseless, hysteria-fueling claims about HIV and AIDS to any news outlet that would put him on. His claim that children could contract the virus from “ordinary household conduct” with an infected relative proved so outrageous he had to walk it back,3 and he never really stopped insisting the deadly plague associated with gays and drug users was about to explode like a nuclear bomb among the law-abiding heterosexual population. Fauci by this time controlled all government science funding through NIAID, and his zero-tolerance approach to dissent on the HIV/AIDS front had already seen prominent scientists like virologist Peter Duesberg stripped of the resources they needed for their work because they had dared to question his commandment: There is no cause of AIDS but HIV, and AZT is its treatment. Even the AIDS activist groups, which by then had been coopted by Big Pharma and essentially reduced to astroturfing for the toxic failed chemotherapy drug AZT backed by the institutional might of Fauci's NIAID,4 didn't seem to want to hear that there was a cure. Unconcerned with the irrationality of denouncing the man touting his free AIDS cure as an  “AIDS denier,” they warned journalists that platforming Null or anyone else rejecting the mainstream medical line would be met with organized demands for their firing.    Determined to breach the institutional iron curtain and get his message to the masses, Null and his team staged a press conference in New York, inviting scientists and doctors from around the world to share their research on alternative approaches to HIV and AIDS in 1993. To emphasize the sound scientific basis of the Center's protocols and encourage guests to adopt them into their own practices, Null printed out thousands of abstracts in support of each nutrient and treatment being used. However, despite over 7,000 invitations sent three times to major media, government figures, scientists, and activists, almost none of the intended audience members showed up. Over 100 AIDS patients and their doctors, whose charts exhaustively documented their improvements using natural and nontoxic modalities over the preceding 12 months, gave filmed testimonials, declaring that the feared disease was no longer a death sentence, but the conference had effectively been silenced. Bill Tatum, publisher of the Amsterdam News, suggested Null and his patients would find a more welcoming audience in his home neighborhood of Harlem - specifically, its iconic Apollo Theatre. For three nights, the theater was packed to capacity. Hit especially hard by the epidemic and distrustful of a medical system that had only recently stopped being openly racist (the Tuskegee syphilis experiment only ended in 1972), black Americans, at least, did not seem to care what Anthony Fauci would do if he found out they were investigating alternatives to AZT and death.    PBS journalist Tony Brown, having obtained a copy of the video of patient testimonials from the failed press conference, was among a handful of black journalists who began visiting the Center to investigate the legitimacy of Null's claims. Satisfied they had something significant to offer his audience, Brown invited eight patients - along with Null himself - onto his program over the course of several episodes to discuss the work. It was the first time these protocols had received any attention in the media, despite Null having released nearly two dozen articles and multiple documentaries on the subject by that time. A typical patient on one program, Al, a recovered IV drug user who was diagnosed with AIDS at age 32, described how he “panicked,” saw a doctor and started taking AZT despite his misgivings - only to be forced to discontinue the drug after just a few weeks due to his condition deteriorating rapidly. Researching alternatives brought him to Null, and after six months of “detoxing [his] lifestyle,” he observed his initial symptoms - swollen lymph nodes and weight loss - begin to reverse, culminating with sero-deconversion. On Bill McCreary's Channel 5 program, a married couple diagnosed with HIV described how they watched their T-cell counts increase as they cut out sugar, caffeine, smoking, and drinking and began eating a healthy diet. They also saw the virus leave their bodies.   For HIV-positive viewers surrounded by fear and negativity, watching healthy-looking, cheerful “AIDS patients” detail their recovery while Null backed up their claims with charts must have been balm for the soul. But the TV programs were also a form of outreach to the medical community, with patients' charts always on hand to convince skeptics the cure was scientifically valid. Null brought patients' charts to every program, urging them to keep an open mind: “Other physicians and public health officials should know that there's good science in the alternative perspective. It may not be a therapy that they're familiar with, because they're just not trained in it, but if the results are positive, and you can document them…” He challenged doubters to send in charts from their own sero-deconverted patients on AZT, and volunteered to debate proponents of the orthodox treatment paradigm - though the NIH and WHO both refused to participate in such a debate on Tony Brown's Journal, following Fauci's directive prohibiting engagement with forbidden ideas.    Aside from those few TV programs and Null's own films, suppression of Null's AIDS cure beyond word of mouth was total. The 2021 documentary The Cost of Denial, produced by the Society for Independent Journalists, tells the story of the Tri-State Healing Center and the medical paradigm that sought to destroy it, lamenting the loss of the lives that might have been saved in a more enlightened society. Nurse practitioner Luanne Pennesi, who treated many of the AIDS patients at the Center, speculated in the film that the refusal by the scientific establishment and AIDS activists to accept their successes was financially motivated. “It was as if they didn't want this information to get out. Understand that our healthcare system as we know it is a corporation, it's a corporate model, and it's about generating revenue. My concern was that maybe they couldn't generate enough revenue from these natural approaches.”5   Funding was certainly the main disciplinary tool Fauci's NIAID used to keep the scientific community in line. Despite the massive community interest in the work being done at the Center, no foundation or institution would defy Fauci and risk getting itself blacklisted, leaving Null to continue funding the operation out of his pocket with the profits from book sales. After 15 years, he left the Center in 1995, convinced the mainstream model had so thoroughly been institutionalized that there was no chance of overthrowing it. He has continued to counsel patients and advocate for a reappraisal of the HIV=AIDS hypothesis and its pharmaceutical treatments, highlighting the deeply flawed science underpinning the model of the disease espoused by the scientific establishment in 39 articles, six documentaries and a 700-page textbook on AIDS, but the Center's achievements have been effectively memory-holed by Fauci's multi-billion-dollar propaganda apparatus.     FRUIT OF THE POISONOUS TREE   To understand just how much of a threat Null's work was to the HIV/AIDS establishment, it is instructive to revisit the 1984 paper, published by Dr. Robert Gallo of the National Cancer Institute, that established HIV as the sole cause of AIDS. The CDC's official recognition of AIDS in 1981 had done little to quell the mounting public panic over the mysterious illness afflicting gay men in the US, as the agency had effectively admitted it had no idea what was causing them to sicken and die. As years passed with no progress determining the causative agent of the plague, activist groups like Gay Men's Health Crisis disrupted public events and threatened further mass civil disobedience as they excoriated the NIH for its sluggish allocation of government science funding to uncovering the cause of the “gay cancer.”6 When Gallo published his paper declaring that the retrovirus we now know as HIV was the sole “probable” cause of AIDS, its simple, single-factor hypothesis was the answer to the scientific establishment's prayers. This was particularly true for Fauci, as the NIAID chief was able to claim the hot new disease as his agency's own domain in what has been described as a “dramatic confrontation” with his rival Sam Broder at the National Cancer Institute. After all, Fauci pointed out, Gallo's findings - presented by Health and Human Services Secretary Margaret Heckler as if they were gospel truth before any other scientists had had a chance to inspect them, never mind conduct a full peer review - clearly classified AIDS as an infectious disease, and not a cancer like the Kaposi's sarcoma which was at the time its most visible manifestation. Money and media attention began pouring in, even as funding for the investigation of other potential causes of AIDS dried up. Having already patented a diagnostic test for “his” retrovirus before introducing it to the world, Gallo was poised for a financial windfall, while Fauci was busily leveraging the discovery into full bureaucratic empire of the US scientific apparatus.   While it would serve as the sole basis for all US government-backed AIDS research to follow - quickly turning Gallo into the most-cited scientist in the world during the 1980s,7 Gallo's “discovery” of HIV was deeply problematic. The sample that yielded the momentous discovery actually belonged to Prof. Luc Montagnier of the French Institut Pasteur, a fact Gallo finally admitted in 1991, four years after a lawsuit from the French government challenged his patent on the HIV antibody test, forcing the US government to negotiate a hasty profit-sharing agreement between Gallo's and Montagnier's labs. That lawsuit triggered a cascade of official investigations into scientific misconduct by Gallo, and evidence submitted during one of these probes, unearthed in 2008 by journalist Janine Roberts, revealed a much deeper problem with the seminal “discovery.” While Gallo's co-author, Mikulas Popovic, had concluded after numerous experiments with the French samples that the virus they contained was not the cause of AIDS, Gallo had drastically altered the paper's conclusion, scribbling his notes in the margins, and submitted it for publication to the journal Science without informing his co-author.   After Roberts shared her discovery with contacts in the scientific community, 37 scientific experts wrote to the journal demanding that Gallo's career-defining HIV paper be retracted from Science for lacking scientific integrity.8 Their call, backed by an endorsement from the 2,600-member scientific organization Rethinking AIDS, was ignored by the publication and by the rest of mainstream science despite - or perhaps because of - its profound implications.   That 2008 letter, addressed to Science editor-in-chief Bruce Alberts and copied to American Association for the Advancement of Science CEO Alan Leshner, is worth reproducing here in its entirety, as it utterly dismantles Gallo's hypothesis - and with them the entire HIV is the sole cause of AIDS dogma upon which the contemporary medical model of the disease rests:   On May 4, 1984 your journal published four papers by a group led by Dr. Robert Gallo. We are writing to express our serious concerns with regard to the integrity and veracity of the lead paper among these four of which Dr. Mikulas Popovic is the lead author.[1] The other three are also of concern because they rely upon the conclusions of the lead paper .[2][3][4]  In the early 1990s, several highly critical reports on the research underlying these papers were produced as a result of governmental inquiries working under the supervision of scientists nominated by the National Academy of Sciences and the Institute of Medicine. The Office of Research Integrity of the US Department of Health and Human Services concluded that the lead paper was “fraught with false and erroneous statements,” and that the “ORI believes that the careless and unacceptable keeping of research records...reflects irresponsible laboratory management that has permanently impaired the ability to retrace the important steps taken.”[5] Further, a Congressional Subcommittee on Oversight and Investigations led by US Representative John D. Dingell of Michigan produced a staff report on the papers which contains scathing criticisms of their integrity.[6]  Despite the publically available record of challenges to their veracity, these papers have remained uncorrected and continue to be part of the scientific record.  What prompts our communication today is the recent revelation of an astonishing number of previously unreported deletions and unjustified alterations made by Gallo to the lead paper. There are several documents originating from Gallo's laboratory that, while available for some time, have only recently been fully analyzed. These include a draft of the lead paper typewritten by Popovic which contains handwritten changes made to it by Gallo.[7] This draft was the key evidence used in the above described inquiries to establish that Gallo had concealed his laboratory's use of a cell culture sample (known as LAV) which it received from the Institut Pasteur.  These earlier inquiries verified that the typed manuscript draft was produced by Popovic who had carried out the recorded experiment while his laboratory chief, Gallo, was in Europe and that, upon his return, Gallo changed the document by hand a few days before it was submitted to Science on March 30, 1984. According to the ORI investigation, “Dr. Gallo systematically rewrote the manuscript for what would become a renowned LTCB [Gallo's laboratory at the National Cancer Institute] paper.”[5]  This document provided the important evidence that established the basis for awarding Dr. Luc Montagnier and Dr. Francoise Barré-Sinoussi the 2008 Nobel Prize in Medicine for the discovery of the AIDS virus by proving it was their samples of LAV that Popovic used in his key experiment. The draft reveals that Popovic had forthrightly admitted using the French samples of LAV renamed as Gallo's virus, HTLV-III, and that Gallo had deleted this admission, concealing their use of LAV.  However, it has not been previously reported that on page three of this same document Gallo had also deleted Popovic's unambiguous statement that, "Despite intensive research efforts, the causative agent of AIDS has not yet been identified,” replacing it in the published paper with a statement that said practically the opposite, namely, “That a retrovirus of the HTLV family might be an etiologic agent of AIDS was suggested by the findings.”  It is clear that the rest of Popovic's typed paper is entirely consistent with his statement that the cause of AIDS had not been found, despite his use of the French LAV. Popovic's final conclusion was that the culture he produced “provides the possibility” for detailed studies. He claimed to have achieved nothing more. At no point in his paper did Popovic attempt to prove that any virus caused AIDS, and it is evident that Gallo concealed these key elements in Popovic's experimental findings.  It is astonishing now to discover these unreported changes to such a seminal document. We can only assume that Gallo's alterations of Popovic's conclusions were not highlighted by earlier inquiries because the focus at the time was on establishing that the sample used by Gallo's lab came from Montagnier and was not independently collected by Gallo. In fact, the only attention paid to the deletions made by Gallo pertains to his effort to hide the identity of the sample. The questions of whether Gallo and Popovic's research proved that LAV or any other virus was the cause of AIDS were clearly not considered.  Related to these questions are other long overlooked documents that merit your attention. One of these is a letter from Dr. Matthew A. Gonda, then Head of the Electron Microscopy Laboratory at the National Cancer Institute, which is addressed to Popovic, copied to Gallo and dated just four days prior to Gallo's submission to Science.[8] In this letter, Gonda remarks on samples he had been sent for imaging because “Dr Gallo wanted these micrographs for publication because they contain HTLV.” He states, “I do not believe any of the particles photographed are of HTLV-I, II or III.” According to Gonda, one sample contained cellular debris, while another had no particles near the size of a retrovirus. Despite Gonda's clearly worded statement, Science published on May 4, 1984 papers attributed to Gallo et al with micrographs attributed to Gonda and described unequivocally as HTLV-III.  In another letter by Gallo, dated one day before he submitted his papers to Science, Gallo states, “It's extremely rare to find fresh cells [from AIDS patients] expressing the virus... cell culture seems to be necessary to induce virus,” a statement which raises the possibility he was working with a laboratory artifact. [9]  Included here are copies of these documents and links to the same. The very serious flaws they reveal in the preparation of the lead paper published in your journal in 1984 prompts our request that this paper be withdrawn. It appears that key experimental findings have been concealed. We further request that the three associated papers published on the same date also be withdrawn as they depend on the accuracy of this paper.  For the scientific record to be reliable, it is vital that papers shown to be flawed, or falsified be retracted. Because a very public record now exists showing that the Gallo papers drew unjustified conclusions, their withdrawal from Science is all the more important to maintain integrity. Future researchers must also understand they cannot rely on the 1984 Gallo papers for statements about HIV and AIDS, and all authors of papers that previously relied on this set of four papers should have the opportunity to consider whether their own conclusions are weakened by these revelations.      Gallo's handwritten revision, submitted without his colleague's knowledge despite multiple experiments that failed to support the new conclusion, was the sole foundation for the HIV=AIDS hypothesis. Had Science published the manuscript the way Popovic had typed it, there would be no AIDS “pandemic” - merely small clusters of people with AIDS. Without a viral hypothesis backing the development of expensive and deadly pharmaceuticals, would Fauci have allowed these patients to learn about the cure that existed all along?   Faced with a potential rebellion, Fauci marshaled the full resources under his control to squelch the publication of the investigations into Gallo and restrict any discussion of competing hypotheses in the scientific and mainstream press, which had been running virus-scare stories full-time since 1984. The effect was total, according to biochemist Dr. Kary Mullis, inventor of the polymerase chain reaction (PCR) procedure. In a 2009 interview, Mullis recalled his own shock when he attempted to unearth the experimental basis for the HIV=AIDS hypothesis. Despite his extensive inquiry into the literature, “there wasn't a scientific reference…[that] said ‘here's how come we know that HIV is the probable cause of AIDS.' There was nothing out there like that.”9 This yawning void at the core of HIV/AIDS “science" turned him into a strident critic of AIDS dogma - and those views made him persona non grata where the scientific press was concerned, suddenly unable to publish a single paper despite having won the Nobel Prize for his invention of the PCR test just weeks before.  10   DISSENT BECOMES “DENIAL”   While many of those who dissent from the orthodox HIV=AIDS view believe HIV plays a role in the development of AIDS, they point to lifestyle and other co-factors as being equally if not more important. Individuals who test positive for HIV can live for decades in perfect health - so long as they don't take AZT or the other toxic antivirals fast-tracked by Fauci's NIAID - but those who developed full-blown AIDS generally engaged in highly risky behaviors like extreme promiscuity and prodigious drug abuse, contracting STDs they took large quantities of antibiotics to treat, further running down their immune systems. While AIDS was largely portrayed as a “gay disease,” it was only the “fast track” gays, hooking up with dozens of partners nightly in sex marathons fueled by “poppers” (nitrate inhalants notorious for their own devastating effects on the immune system), who became sick. Kaposi's sarcoma, one of the original AIDS-defining conditions, was widespread among poppers-using gay men, but never appeared among IV drug users or hemophiliacs, the other two main risk groups during the early years of the epidemic. Even Robert Gallo himself, at a 1994 conference on poppers held by the National Institute on Drug Abuse, would admit that the previously-rare form of skin cancer surging among gay men was not primarily caused by HIV - and that it was immune stimulation, rather than suppression, that was likely responsible.11 Similarly, IV drug users are often riddled with opportunistic infections as their habit depresses the immune system and their focus on maintaining their addiction means that healthier habits - like good nutrition and even basic hygiene - fall by the wayside.    Supporting the call for revising the HIV=AIDS hypothesis to include co-factors is the fact that the mass heterosexual outbreaks long predicted by Fauci and his ilk in seemingly every country on Earth have failed to materialize, except - supposedly - in Africa, where the diagnostic standard for AIDS differs dramatically from those of the West. Given the prohibitively high cost of HIV testing for poor African nations, the WHO in 1985 crafted a diagnostic loophole that became known as the “Bangui definition,” allowing medical professionals to diagnose AIDS in the absence of a test using just clinical symptoms: high fever, persistent cough, at least 30 days of diarrhea, and the loss of 10% of one's body weight within two months. Often suffering from malnutrition and without access to clean drinking water, many of the inhabitants of sub-Saharan Africa fit the bill, especially when the WHO added tuberculosis to the list of AIDS-defining illnesses in 1993 - a move which may be responsible for as many as one half of African “AIDS” cases, according to journalist Christine Johnson. The WHO's former Chief of Global HIV Surveillance, James Chin, acknowledged their manipulation of statistics, but stressed that it was the entire AIDS industry - not just his organization - perpetrating the fraud. “There's the saying that, if you knew what sausages are made of, most people would hesitate to sort of eat them, because they wouldn't like what's in it. And if you knew how HIV/AIDS numbers are cooked, or made up, you would use them with extreme caution,” Chin told an interviewer in 2009.12   With infected numbers stubbornly remaining constant in the US despite Fauci's fearmongering projections of the looming heterosexually-transmitted plague, the CDC in 1993 broadened its definition of AIDS to include asymptomatic (that is, healthy) HIV-positive people with low T-cell counts - an absurd criteria given that an individual's T-cell count can fluctuate by hundreds within a single day. As a result, the number of “AIDS cases” in the US immediately doubled. Supervised by Fauci, the NIAID had been quietly piling on diseases into the “AIDS-related” category for years, bloating the list from just two conditions - pneumocystis carinii pneumonia and Kaposi's sarcoma - to 30 so fast it raised eyebrows among some of science's leading lights. Deeming the entire process “bizarre” and unprecedented, Kary Mullis wondered aloud why no one had called the AIDS establishment out: “There's something wrong here. And it's got to be financial.”13   Indeed, an early CDC public relations campaign was exposed by the Wall Street Journal in 1987 as having deliberately mischaracterized AIDS as a threat to the entire population so as to garner increased public and private funding for what was very much a niche issue, with the risk to average heterosexuals from a single act of sex “smaller than the risk of ever getting hit by lightning.” Ironically, the ads, which sought to humanize AIDS patients in an era when few Americans knew anyone with the disease and more than half the adult population thought infected people should be forced to carry cards warning of their status, could be seen as a reaction to the fear tactics deployed by Fauci early on.14   It's hard to tell where fraud ends and incompetence begins with Gallo's HIV antibody test. Much like Covid-19 would become a “pandemic of testing,” with murder victims and motorcycle crashes lumped into “Covid deaths” thanks to over-sensitized PCR tests that yielded as many as 90% false positives,15 HIV testing is fraught with false positives - and unlike with Covid-19, most people who hear they are HIV-positive still believe they are receiving a death sentence. Due to the difficulty of isolating HIV itself from human samples, the most common diagnostic tests, ELISA and the Western Blot, are designed to detect not the virus but antibodies to it, upending the traditional medical understanding that the presence of antibodies indicates only exposure - and often that the body has actually vanquished the pathogen. Patients are known to test positive for HIV antibodies in the absence of the virus due to at least 70 other conditions, including hepatitis, lupus, rheumatoid arthritis, syphilis, recent vaccination or even pregnancy. (https://www.chcfl.org/diseases-that-can-cause-a-false-positive-hiv-test/) Positive results are often followed up with a PCR “viral load” test, even though the inventor of the PCR technique Kary Mullis famously condemned its misuse as a tool for diagnosing infection. Packaging inserts for all three tests warn the user that they cannot be reliably used to diagnose HIV.16 The ELISA HIV antibody test explicitly states: “At present there is no recognized standard for establishing the presence and absence of HIV antibody in human blood.”17   That the public remains largely unaware of these and other massive holes in the supposedly airtight HIV=AIDS=DEATH paradigm is a testament to Fauci's multi-layered control of the press. Like the writers of the Great Barrington Declaration and other Covid-19 dissidents, scientists who question HIV/AIDS dogma have been brutally punished for their heresy, no matter how prestigious their prior standing in the field and no matter how much evidence they have for their own claims. In 1987, the year the FDA's approval of AZT made AIDS the most profitable epidemic yet (a dubious designation Covid-19 has since surpassed), Fauci made it clearer than ever that scientific inquiry and debate - the basis of the scientific method - would no longer be welcome in the American public health sector, eliminating retrovirologist Peter Duesberg, then one of the most prominent opponents of the HIV=AIDS hypothesis, from the scientific conversation with a professional disemboweling that would make a cartel hitman blush. Duesberg had just eviscerated Gallo's 1984 HIV paper with an article of his own in the journal Cancer Research, pointing out that retroviruses had never before been found to cause a single disease in humans - let alone 30 AIDS-defining diseases. Rather than allow Gallo or any of the other scientists in his camp to respond to the challenge, Fauci waged a scorched-earth campaign against Duesberg, who had until then been one of the most highly regarded researchers in his field. Every research grant he requested was denied; every media appearance was canceled or preempted. The University of California at Berkeley, unable to fully fire him due to tenure, took away his lab, his graduate students, and the rest of his funding. The few colleagues who dared speak up for him in public were also attacked, while enemies and opportunists were encouraged to slander Duesberg at the conferences he was barred from attending and in the journals that would no longer publish his replies. When Duesberg was summoned to the White House later that year by then-President Ronald Reagan to debate Fauci on the origins of AIDS, Fauci convinced the president to cancel, allegedly pulling rank on the Commander-in-Chief with an accusation that the “White House was interfering in scientific matters that belonged to the NIH and the Office of Science and Technology Assessment.” After seven years of this treatment, Duesberg was contacted by NIH official Stephen O'Brien and offered an escape from professional purgatory. He could have “everything back,” he was told, and shown a manuscript of a scientific paper - apparently commissioned by the editor of the journal Nature - “HIV Causes AIDS: Koch's Postulates Fulfilled” with his own name listed alongside O'Brien's as an author.18 His refusal to take the bribe effectively guaranteed the epithet “AIDS denier” will appear on his tombstone. The character assassination of Duesberg became a template that would be deployed to great effectiveness wherever Fauci encountered dissent - never debate, only demonize, deplatform and destroy.    Even Luc Montagnier, the real discoverer of HIV, soon found himself on the wrong side of the Fauci machine. With his 1990 declaration that “the HIV virus [by itself] is harmless and passive, a benign virus,” Montagnier began distancing himself from Gallo's fraud, effectively placing a target on his own back. In a 1995 interview, he elaborated: “four factors that have come together to account for the sudden epidemic [of AIDS]: HIV presence, immune hyper-activation, increased sexually transmitted disease incidence, sexual behavior changes and other behavioral changes” such as drug use, poor nutrition and stress - all of which he said had to occur “essentially simultaneously” for HIV to be transmitted, creating the modern epidemic. Like the professionals at the Tri-State Healing Center, Montagnier advocated for the use of antioxidants like vitamin C and N-acetyl cysteine, naming oxidative stress as a critical factor in the progression from HIV to AIDS.19 When Montagnier died in 2022, Fauci's media mouthpieces sneered that the scientist (who was awarded the Nobel Prize in 2008 for his discovery of HIV, despite his flagging faith in that discovery's significance) “started espousing views devoid of a scientific basis” in the late 2000s, leading him to be “shunned by the scientific community.”20 In a particularly egregious jab, the Washington Post's obit sings the praises of Robert Gallo, implying it was the American scientist who really should have won the Nobel for HIV, while dismissing as “

covid-19 america tv american new york director university california death money head health children donald trump europe earth science house washington coronavirus future americans french young san francisco west doctors phd society africa michigan office chinese joe biden evolution elon musk healthy european union dna microsoft new jersey western cost medicine positive study recovery chief barack obama healthcare institute numbers illinois congress white house african trial cnn journal patients draft myth prof solution medical republicans ceos wall street journal manhattan tribute private rescue washington post reddit connecticut democrats phase prep campaign millions bernie sanders blame nurses wikipedia funding united nations basic cdc prevention secretary fda iv hiv senators individual bill gates pbs aids amid berkeley pi physicians armed pfizer older defenders poison epidemics denial individuals sciences nigerians medicare nancy pelosi big tech possibilities nobel national institutes medications scientific broken aa world health organization ama determined anthony fauci gdp moderna faced nobel prize poll defined syracuse ronald reagan princeton university advancement medicaid satisfied rand prescription koch ironically american association continuous human services hiv aids allergies chin investigations us department big pharma us senate new deal mrna nih robert f kennedy jr national academy obamacare packaging huffpost infectious diseases ayurvedic kenyan clip deep state aid justice department pcr researching gays razor gallo affordable care act establishment orphans stonewall etienne merck aca oecd oversight korean war ori lancet skeptics asd jama stds dissent chuck schumer expos gilead commander in chief traditional chinese medicine hhs american medical association cancer research robert f kennedy drug abuse saharan africa melinda gates foundation pcp health crisis oxycontin pis gavi lav gay men tuskegee isaac hayes national cancer institute h5n1 bmj famously documented legions operation warp speed farber robert kennedy jr archived pfizer covid hmo azt american conservative gannett congressional budget office act up nejm supervised discriminatory kafkaesque anti aging medicine life extension kaiser family foundation marketed avram tony brown koch brothers nci pcr tests niaid poz health affairs kaiser health news gateway pundit great barrington declaration larry kramer popovic apollo theatre aids/hiv skyhorse publishing unaids real anthony fauci pbd bangui new york press stokely carmichael health defense institut pasteur kff nuremberg code ddi ezekiel emanuel deeming truvada technology assessment kary mullis doxycycline unconcerned kaposi vioxx national health program luc montagnier gonda new york native mercatus ken mccarthy plos medicine health office christine johnson western blot amsterdam news research integrity gary null robert gallo un secretary general ban ki celia farber bactrim applied biology htlv james chin safe cosmetics stacy malkan uwe reinhardt duesberg michael callen
The Fly Widow
Episode 33: How Safe Are Products Marketed to Black Women?

The Fly Widow

Play Episode Listen Later Feb 17, 2025 14:17


In this episode, Dr. Alisha Reed discusses the importance of being mindful about the personal care products marketed to black women. She highlights the findings of the EWG report, which reveals that these products often contain harmful chemicals linked to serious health issues. Dr. Reed emphasizes the need for consumers to be informed and advocate for safer alternatives, while also providing resources and recommendations for healthier living.   Link to report: EWG Report Link to EWG Database: https://www.ewg.org/skindeep/ Link to BLK+GRN: BLK + GRN: An all natural marketplace by all Black women artisans Link to BGE: https://blackgirlenvironmentalist.org/ Follow: Instagram (@dralishareed) Join Email List: Join the Grown Woman Self-Care Journey!

Online Marketing Moves with Tony Resonno
Why are Condoms Marketed so Poorly?

Online Marketing Moves with Tony Resonno

Play Episode Listen Later Feb 16, 2025 19:20


Elon Musk has 100 kids he needs them. Nick Cannon has 100 he needs them. I'm talking condoms on today's episode. Where is in the marketing of condoms? You ever see a ad for them? I don't. They sell penis pills on tv daily but nothing for the wrap around it. Interesting. I discuss condoms, marriage, and marketing lanes on today's episode. Email Tony@tonyresonno.com

Travolting
The Survivors

Travolting

Play Episode Listen Later Jan 22, 2025 42:31


Jeff and Stuart barely "survived" watching this movie. Marketed as a two-hander between Robin and Walter Matthau, this movie nails the jokes just as well as the plot: fast and unintelligible.

Small Business, Big Network
The Marketing Coach for Coach-Shaped People

Small Business, Big Network

Play Episode Listen Later Jan 20, 2025 24:23


BioJanine Coombes is a marketing coach for coach-shaped-people who want to earn more without slogging their guts out. She's an offer positioning expert with extensive experience including working with big brands like EE, Orange and Europcar. She has a business degree, a post-graduate marketing diploma (CIM Dip) and regularly speaks on stages like Atomicon, You Are The Media and MarketEd.Live. She's a skilled writer and loves to be on video-garnering international attention with The Secret Marketing Show.Linkshttps://www.linkedin.com/in/janinecoombeshttps://www.janinecoombes.co.ukhttps://www.janinecoombes.co.uk/jetpack (free sales course for coaches)

KQED's The California Report
Wrinkle Cream Among Cosmetics Marketed To Teens

KQED's The California Report

Play Episode Listen Later Dec 25, 2024 11:40


If you've found yourself at a makeup store recently, especially in a mall after school, you might've noticed more young people around you. Like really young. Like elementary and middle school young. This is a trend and it has a name: Sephora Kids. And their purchases are doing damage to more than just their parents' bank accounts. Reporter: Caleigh Wells, KCRW As the saying goes, one person's trash is another's treasure. And that's true at a landfill in Riverside County. Workers at the Lamb Canyon Landfill have started rescuing items to resell at a new store.  Reporter: Madison Aument, KVCR  Learn more about your ad choices. Visit megaphone.fm/adchoices

Ad Law Access Podcast
Connecticut AG Investigates Skincare Products Marketed To Kids

Ad Law Access Podcast

Play Episode Listen Later Dec 23, 2024 3:19


If you've been on social media lately, depending on your algorithm, you may have witnessed tween influencers touting expensive skincare routines, or commentators lamenting the rise of the Sephora Kid. Before the holiday, Connecticut AG William Tong urged parents to exercise caution regarding anti-aging skincare products that are being marketed to children and teens by influencers on social media. The AG is concerned that many of these products include ingredients that are unsuitable, or even harmful, for kids. The AG also sent a detailed inquiry 21-request ​“letter” (looking similar to a CID) to Sephora asking about how it markets these products to kids. https://www.kelleydrye.com/viewpoints/blogs/ad-law-access/connecticut-ag-investigates-skincare-products-marketed-to-kids Gonzalo Mon gmon@kelleydrye.com (202) 342-8576 www.kelleydrye.com/people/gonzalo-e-mon Beth Chun bchun@kelleydrye.com (202) 342-8671 www.kelleydrye.com/Our-People/Beth-Bolen-Chun Hosted by Simone Roach Subscribe to the Ad Law Access blog - www.kelleydrye.com/subscribe Subscribe to the Ad Law News Newsletter - www.kelleydrye.com/subscribe View the Advertising and Privacy Law Resource Center - www.kelleydrye.com/advertising-and-privacy-law Find all of our links here linktr.ee/KelleyDryeAdLaw

Taste Radio
No Joke, This Comedian's ‘Basic' Brand Gives Modern Consumers What They Want

Taste Radio

Play Episode Listen Later Dec 17, 2024 33:21


Being “basic” has long been a theme of Trey Kennedy's popular standup routine and sketch comedy. He recently introduced the perfect pairing for his humor, Basic Cellars. An Instagram sensation with over three million followers, Trey debuted Basic Cellars in October.  Created in partnership with premium wine producer In Good Taste, the brand is designed to appeal to modern consumers who love wine, but are often put off by complicated and confusing verbiage. Basic Cellars sells two wines, a California Pinot Noir and an Italian white, that come in single-serve 187 mL glass bottles. Marketed as “wine for people who don't take themselves too seriously,” Basic Cellars is sold online in eight-packs for $60. The brand is gradually making its way into brick-and-mortar stores, according to Trey, who recently joined us for an interview. As part of our conversation, Trey talks about how Basic Cellars melds his passion for comedy and wine, how the brand presents itself as a both an accessible and premium option, how its core audience aligns with that of his own and how he attempts to authentically incorporate the brand into his social media content. Show notes: 0:25: Trey Kennedy, Founder, Basic Cellars – Trey chats with Taste Radio editor Ray Latif about how he embraced wine after he “graduated” from beer and why the beverage is popular with his fanbase. He also talks about the reason for Basic Cellars' bottle size, whether featuring the brand in his social posts has generated significant sales and how he attempts to create content that doesn't feel like an ad. Trey also discusses his process for promoting other companies, whether Basic Cellars will begin to sell merchandise, the potential to extend the brand into other beverage categories and how he incorporates consumer feedback into business planning. He also talks about the company's retail strategy and potential collaborations and shares his take on the most effective social media platforms. Brands in this episode: Basic Cellars, Loverboy

Cherokee Tribune-Ledger Podcast
Chick-fil-A's First Penny Press Comes to Canton

Cherokee Tribune-Ledger Podcast

Play Episode Listen Later Dec 10, 2024 11:44


CTL Script/ Top Stories of December 10th Publish Date: December 10th   Pre-Roll: From the Ingles Studio Welcome to the Award-Winning Cherokee Tribune Ledger Podcast  Today is Tuesday, December 10th and Happy Birthday to 7 Nation’s Med White ***12.10.24 - BIRTHDAY – MED WHITE*** I’m Keith Ippolito and here are the stories Cherokee is talking about, presented by Credit Union of Georgia.  Chick-fil-A’s First Penny Press Comes to Canton Cherokee Schools Improves College and Career Readiness Scores Former Woodstock Police Officer Pleads Guilty to Killing Marietta Motorist Plus, Leah McGrath from Ingles Markets on feeding a picky toddler. We’ll have all this and more coming up on the Cherokee Tribune-Ledger Podcast, and if you’re looking for Community news, we encourage you to listen and subscribe!  Commercial: CU of GA (06.26.24 CU OF GA FREE CHECKING_REV_FINAL) STORY 1: Chick-fil-A’s First Penny Press Comes to Canton Chick-fil-A's Riverstone location in Canton has introduced the Canton Kindness Coins penny press machine, offering five unique collector coins, including a Truett Cathy coin honoring Chick-fil-A's founder. Guests can press their own penny for free, with optional donations supporting the Cherokee County nonprofit New Ground Foundation, which aids foster and adoptive families. Chick-fil-A will match donations up to $25,000 through December 31, with $100 donors receiving a collector’s book of all five coins. The machine celebrates Canton and supports community uplift, with plans to rotate to other Canton locations. STORY 2: Cherokee Schools Improves College and Career Readiness Scores The Cherokee County School District (CCSD) improved its College and Career Readiness Performance Index (CCRPI) scores across elementary, middle, and high school levels for the 2023-24 school year, surpassing state averages in many areas. Highlights include an elementary Content Mastery score of 79.3, middle school score of 74.2, and high school score of 81.7, all outperforming Georgia's averages. Notably, the district achieved a perfect 100 in elementary Closing Gaps and significant progress in middle school Closing Gaps at 77.8, both exceeding state averages. The high school graduation rate climbed to 93.5%, ranking third highest in metro Atlanta and well above the state’s 85.4%. The district credits the success to the dedication of students, educators, and leaders, further strengthening its commitment to academic excellence. STORY 3: Former Woodstock Police Officer Pleads Guilty to Killing Marietta Motorist Former Woodstock Police officer Grant Shaw pled guilty to involuntary manslaughter in the fatal shooting of 20-year-old Emmanuel Malik Millard after an October 2023 police chase. Prosecutors sought a 10-year sentence with 2 years in prison, but the judge suspended the sentence, instead assigning Shaw 500 hours of community service. The incident occurred when Millard fled a traffic stop, leading officers on a pursuit that ended in Cobb County. After police used a PIT maneuver to stop Millard's car, Shaw fired a single shot, striking Millard, who later died. Shaw resigned from the force a week after the incident. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info.    Back in a moment  Break: Drake (Drake Realty (Cherokee County) STORY 4: Canton City Council to Vote on 198-Unit Condo Plan Dec. 19 O’Dwyer Properties has proposed building 198 condominiums in Canton on 14.91 acres along April and Lucky Streets near Highway 140. The plan includes 11 three-story buildings with six units per floor, offering one- and two-bedroom condos. Marketed as “missing middle” housing, the project aims to appeal to younger, smaller families. However, concerns have been raised about the density exceeding the area's future land use plan recommendation of 4-6 units per acre, traffic impacts on Highway 140, infrastructure strain, and affordability. The Canton City Council will vote on the annexation, rezoning, and conditional use permit on Dec. 19. STORY 5: Cherokee Postpones Votes on Townhome Development to Dec. 17 Cherokee County commissioners have postponed two votes on a proposed 102-townhome development near Patriots Park following public opposition. Developer Ashton Woods plans to build on 10.3 acres at Kellogg Creek Road and Victory Drive, with townhome sizes ranging from 880 to 1,176 square feet and a proposed density of 11.95 units per acre. Changes sought include removing a 2005 zoning condition requiring left turn lanes and reclassifying a 0.66-acre county-parcel to allow seven additional units. Residents voiced traffic and safety concerns, opposed selling the county parcel, and suggested the land could enhance Patriots Park. Nearly 600 people signed a petition against the project. Commissioners will now vote on Dec. 17 to consider all related requests. Commercial: And now here is Leah McGrath from Ingles Markets feeding a picky toddler. *** INGLES 1 (PICKY TODDLER) *** We’ll have closing comments after this.   COMMERCIAL: Ingles Markets 2   SIGN OFF –   Thanks again for hanging out with us on today’s Cherokee Tribune Ledger Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.tribuneledgernews.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com www.drakerealty.com cuofga.org #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

Tech Champagne
Episode 107 - Why Are High-Return Investments Marketed Only To Men?

Tech Champagne

Play Episode Listen Later Dec 6, 2024 21:40


Wanna shake things up on the internet? Start posting about something that is new and misunderstood by a lot of people. I have been posting about stock and crypto currently investing for weeks and the messages I've been getting have been SPICY! I have been investing in these spaces for years and in this episode I am sharing: How to get started. Investments I have made and the outcomes of those. How to track your gains/losses. If you have been following the Crypto space lately (I suggest you start paying attention for sure), then you know the significant growth that is happening. So join me in this week's episode and if you want to join us women who are profiting from these investments, join me in The Money Lab. We start mid-January.

Women Making Moves
Menopause is Not What We're Marketed

Women Making Moves

Play Episode Listen Later Nov 8, 2024 41:00


Carolyn Lewis spent much of her early professional years out on the open waters in maritime and anti-piracy operations. This is where she was met abruptly with the lack of knowledge around women's health, as she was the first one to have her period on a ship! There were no provisions, so she set out on her own to educate and support male dominated industries to support women appropriately as it relates to perimenopause and menopause. We cover a range of topics including a breakdown of the 30+ symptoms of perimenopause, the stages of the process - again on average, because it will impact each unique individual differently. Carolyn's main goal? To meet each and every person uniquely where they are, no matter where in the awareness, acknowledgement, or understanding - she has room for you, without judgement.Find Carolyn on LinkedIn and visit her website for more information - she's always open to a conversation. Thank you for tuning in to Women Making Moves, please rate and subscribe on your favorite platform along with following on Instagram. Visit Amy and her coaching at Unlock the Magic and give a follow on Instagram.Women Making Moves is for personal use only and general information purposes, the show host cannot guarantee the accuracy of any statements from guests or the sufficiency of the information. This show and host is not liable for any personal actions taken.

Badass Records
Episode #143, Robert Flynn

Badass Records

Play Episode Listen Later Nov 7, 2024 182:50


"Hey! Hey! Hey! Whatcha' got to say?!"I don't have any "Hollywood Swingers" action to share with you, but I do have some equally exciting news, and that's that Robert Flynn finally made it by the studio and we sat down together for what wound up being Episode No. 143 of this here podcast.Robert was on my initial-initial outreach list while I was trying to get this thing live and off the ground, and some three years later, here we are.Robert's a son, a sibling, a husband, a father, an Eagle Scout, a scout leader, a former attorney, a high-school government teacher, and a good many other things. We once went through the CRHP program together and have two kids in the same grades together. He's also something of a Deadhead, and when we first talked about trying to make this happen, I think I was asking folks about their all-time-favorite album (singular) as opposed to the current iteration that typically involves several.Regardless, the Grateful Dead's American Beauty (1970) was Robert's immediate selection, and it's one of my all-timers, as well, so I was thrilled to have the opportunity to bullshit with him about it.A number of things transpired since our conversation was recorded, namely the passing of Dead bassist Phil Lesh, and the presidential election here in the "good-ol'" United States. No doubt some of us are singing a version of "U.S. Blues" this week, but that's neither here nor there.Anyway, I really enjoyed this chat, and I hope you will, too.Thank you.copyright disclaimer: I do not own the rights to the audio samples contained within this episode. They are snippets from American Beauty's leadoff, "Box of Rain," and it exists c/o Warner Records Inc. Marketed by Rhino Entertainment Company, a Warner Music Group Company.

Toy Power Podcast
#375: Top 10 Horror Toys Marketed to Kids!

Toy Power Podcast

Play Episode Listen Later Nov 2, 2024 78:30


This week on The Toy Power Podcast, with Halloween still fresh in our minds, we invite DoesTEN back on the show to give us a great insight on how the American's Celebrate this famous Halloween event.  Including some neat stories from his youth.  Then keeping with that similar scarry topic, we embark on creating a Top 10 list, detailing some of the more questionable Horror Themed Toys that where marketed to Kids (pre 2000).  Some of them derive from Horror Films of the same name, and others are stand-alone properties that have Horror themes.  We absolutely must give Swamp Thing a shout-out too as he has been depicted in some quite mature Comicbook story lines too.  Did we miss anything, please let us know!Support the show: http://patreon.com/toypowerpodcastSee omnystudio.com/listener for privacy information.

The Cass and Anthony Podcast
Odd new book marketed to Bills fans

The Cass and Anthony Podcast

Play Episode Listen Later Oct 24, 2024 4:16


We can't seem to get behind this AI generated book idea.  Support the show and follow us here Twitter, Insta, Apple, Amazon, Spotify and the Edge! See omnystudio.com/listener for privacy information.

RTÉ - The Business
Oscar Wilde : the World's first Marketed Celebrity

RTÉ - The Business

Play Episode Listen Later Oct 19, 2024 5:19


A fresh perspective on a cultured figure: Oscar Wilde was the original celebrity endorsed through marketing! While today's stars promote everything from takeout to tents, Wilde did the same in the 1800s. Manuscripts Curator Caoimhe Ní Ghormáin shares more about this fascinating exhibit.

Cancel Me, Baby!
Ep 297: The Political Campaign Marketed Harder than 2000s Abercrombie

Cancel Me, Baby!

Play Episode Listen Later Oct 16, 2024 32:11


Like the nipple bra, your whole existence is a marketing ploy. From music to politics and even philosophy, is everything just being sold to you at this point? What's even real? Do you *really* love your favorite personalities and politicians, or are they just the best at being marketed to you? We are living in a material world and maybe everyone is a material girl… and boy. --- Support this podcast: https://podcasters.spotify.com/pod/show/taylor-ferber/support

Albert说英闻
外媒报道:年轻人疯抢Jellycat

Albert说英闻

Play Episode Listen Later Oct 14, 2024 5:49


● 24岁自学成为同声传译● 25岁为瑞士联邦总统翻译● 关注公众号【Albert英语研习社】回复【福利】● 领取本节目400+视频&文字学习资料● 加赠《Albert三天英语思维特训营》直播● 听说读写译轻松进阶!Jellycats are clawing their way to adult popularity.The stuffed animal brand Jellycat has been around for 25 years, and so has one of its main demographics. Marketed toward "people of all ages," Jellycat is experiencing an unprecedented surge in popularity among adultsFrom grinning croissants and smirking sushi to fuzzy, bipedal woodland creatures and costumed amphibians, you'd have had to be living under a dreadfully dull rock to have missed the age-defying phenomenon.主播:周邦琴Albert●没有名牌大学背景,没有英语专业背景●没有国外留学经历,没有英语生活环境●22岁成为500强公司全球员工英文讲师●24岁自学成为同声传译●25岁为瑞士联邦总统翻译

WWL First News with Tommy Tucker
Foreign seafood is often marketed and sold as Louisiana seafood

WWL First News with Tommy Tucker

Play Episode Listen Later Oct 3, 2024 12:05


Tommy talks with State Senator Pat Connick

The Sustainable Minimalists Podcast
The Problem With Products Marketed To Kids

The Sustainable Minimalists Podcast

Play Episode Listen Later Sep 17, 2024 32:10


Just because a product is marketed to babies or kids doesn't mean it's safe, and new research published just last week has alarming things to say about the presence of phthalates in personal care products for children.  While minimalists know that excess stuff harms our emotional well-being and mental loads, *sustainable* minimalists understand that products can harm our physical health. On today's show: Applying the tenets of sustainable minimalism to the hair and skin products our children use each day.   Here's a preview: [7:00] If phthalates make plastics flexible and bendy, what on earth are they doing in personal care products? [10:00] Don't see the term 'phthalate' on a product's ingredients list? That doesn't mean it's phthalate-free! [13:00] Are phthalates the reason why our daughters are getting their periods younger and younger? [19:00] No 10-step skincare regimen to see here: Here's a 5-step cleanup regimen for your household [25:00] Musings on the tween and teen skincare beauty craze   Resources mentioned: Impact of Skin Care Products on Phthalates and Phthalate Replacements in Children: the ECHO-FGS Ultra-Processed Foods And Cardiovascular Disease: Analysis Of Three Large US Prospective Cohorts And A Systematic Review And Meta-Analysis Of Prospective Cohort Studies Episode #425: The Obesogens Yuka App   Products mentioned on today's show: Giovanni Eco Chic Golden Wheat Deep Cleanse Shampoo  Attitude Baby Leaves Hair And Body Wash Attitude Super Leaves Conditioner Kinship SPF 32 Sunscreen with Zinc Oxide David's Toothpaste Giovanni L.A. Hold Hair Spritz   This show is listener-supported. Thank you for supporting! Join our (free!) Facebook community here. Find your tribe. Sustainable Minimalists are on Facebook, Instagram + Youtube @sustainableminimalists Say hello! MamaMinimalistBoston@gmail.com.  

I'm Uncomfortable
Are the Men OK? Alpha Males, Red Pills, and Toxic Masculinity

I'm Uncomfortable

Play Episode Listen Later Sep 17, 2024 28:03


A few drinks post breakup, a discussion about self-worth, and the revelation of "alpha male" texting techniques led Vanessa and Melissa down the rabbit hole of alpha male influencers. Marketed as self-improvement (which we love) these influencers often lose the plot and warp into misogyny and toxic ideologies.   When did men start believing that society is stacked against them? We trace the roots of the red pill movement and the alarming echo chambers many men find themselves in when they try to seek out support and growth.  Find us on Instagram @imuncomfortable.podcast  DM us with any episode ideas or comments!  --- Support this podcast: https://podcasters.spotify.com/pod/show/imuncomfortablepodcast/support

Trader Merlin
Unpacking Trump's Crypto Project! – 09/12/24

Trader Merlin

Play Episode Listen Later Sep 12, 2024 52:42


Buckle up, traders! In this episode we're diving into the murky waters of President Trump's latest venture—World Liberty Financial, a bold but controversial play in the cryptocurrency space. Marketed as a game-changing financial project, World Liberty Financial is already raising eyebrows and sparking debate. But is it truly a path to financial freedom, or just another money grab with more questions than answers? We'll unpack the details, expose the red flags, and discuss what this means for the future of crypto and your investments. If you're looking to stay ahead of the hype and separate fact from fiction in the crypto world, this is an episode you can't afford to miss. Tune in at 2pm PT today! #Bitcoin #CryptoNews #WorldLibertyFinancial #Trump #InvestSmart #Cryptocurrency Contact TraderMerlin: Email – TraderMerlin@gmail.com Follow TraderMerlin: Twitter: TraderMerlin - https://twitter.com/TraderMerlin IG: TraderMerlin - https://www.instagram.com/tradermerlin/ FB: TraderMerlin  - https://www.facebook.com/TraderMerlin Live Daily Show:  - https://www.youtube.com/channel/UCczw6L9MSllTvWDK1fNlLrg Trading Applications used: -          Clik -          TradeStation -          Tradingview

Dr. Chapa’s Clinical Pearls.

(DISCLOSURE: Sexual Content) Back in April 2023, we released an episode on the “Jade Vaginal Egg” and vaginal weights for vaginal tightening. While we tackled the Jade Egg successfully, we now have a new player on the field: the VAGINAL TIGHTENING STICK. This over the counter “sex aid” can lead to chemical burns and severe vaginal dryness/agglutination. Marketed to improce vaginal laxity, some of these sticks have the real potential to cause tissue damage and scarring- as one of our podcast family members saw firsthand with a patient. Its an interesting market place out there! Listen in for details.

Jagged with Jasravee : Cutting-Edge Marketing Conversations with Thought Leaders
121 - Karuna Rawal on How Nature's Fynd Marketed NASA's Incredible Yellowstone Fungus

Jagged with Jasravee : Cutting-Edge Marketing Conversations with Thought Leaders

Play Episode Listen Later Aug 23, 2024 70:35


Karuna, an entrepreneurial brand builder, shares her journey with Nature's Fynd, a company that developed a new protein source from a unique fungus discovered in Yellowstone National Park. 1. From Outer Space to Your Plate: The Unlikely Origin of Nature's Fynd Nature's Fynd's story began with a NASA research project aimed at understanding how life could survive in extreme environments. This research led to the discovery of a remarkable fungus thriving in Yellowstone National Park's volcanic springs. 2. Revolutionising Protein: A New Frontier in Nutrition Nature's Fynd's fungus can produce protein in just 3 to 4 days, compared to the months or years required by animals and plants. This rapid growth makes it a game-changer in meeting the dietary needs of a growing global population. The protein is also incredibly nutritious, containing 50% protein, 30% fiber, and a variety of vitamins and minerals. Additionally, the fungus thrives in an acidic environment, eliminating the need for antibiotics, pesticides, or hormones, making it a cleaner and healthier protein source. 3. Marketing the Unthinkable: Turning Fungi into Food One of the biggest challenges Nature's Fynd faced was convincing consumers to embrace a fungus-based food. The company focused on taste, understanding that no matter how sustainable or healthy a product is, it must taste good to succeed. Nature's Fynd built its brand around the Explorer archetype, a rare identity in the food industry, which aligned perfectly with their innovative story of pioneering new territories in food production. Through strategic branding and storytelling, they successfully shifted the narrative from “weird” to “wonderful.” 4. Launching in a Pandemic: Nature's Fynd's 2020 Debut Nature's Fynd was set to launch in March 2020, just as the COVID-19 pandemic began. While this timing seemed unfortunate, it turned into an opportunity as consumers sought innovative solutions during the crisis. The brand's message of optimism and innovation resonated with consumers, making their launch a symbol of hope in uncertain times. 5. Navigating Consumer Skepticism: Building Trust with Taste Understanding that taste is the top priority for consumers, Nature's Fynd focused on making their products delicious to gain acceptance, even among skeptics of fungi-based food. Early market research revealed that younger, more open-minded consumers were the most interested in the product. By carefully segmenting the market, the company effectively targeted the most promising customer groups. Recognizing the deep cultural connection people have with food, Nature's Fynd introduced their product in familiar forms like yogurt and cheese spreads, easing the transition to fungi-based foods. Karuna Rawal is the CRO & CMO of Nature's Fynd. Karuna is an accomplished brand builder and Emmy award winner with 25 years of success transforming the world's most iconic brands. Connect with her on Linkedin https://www.linkedin.com/in/karunarawal/ Visit Nature's Fynd https://www.naturesfynd.com Jagged with Jasravee is facilitated by Jasravee Kaur Chandra. Jasravee has over 20 years experience as a Strategic Brand Builder, Communications Leader and Entrepreneur. Please visit Jasravee at https://jasravee.com/ Connect with Jasravee on Linkedin at https://www.linkedin.com/in/jasravee/ Email Jasravee at jasravee@gmail.com Index 00:00 Preview & Introduction to Karuna 02:18 NASA Discovery: From Space to Earth's Future 05:23 Fungi Protein: Nature's Fynd Launched During a Pandemic 12:46 Segmenting the Market: Who Wants to Eat Fungi? 21:08 Content Pillars: Education , Lifestyle, Health, Taste 30:06 Challenge of Habit Change: Yogurt, Cheese, and Beyond 45:38 Food, Creativity, and Sustainability: The Explorer Archetype 51:01 Aligning the Brand with Company Values 52:52 Marketer's Journey: #likeagirl 01:04:35 Rapid Fire with Karuna Rawal 01:08:30 Connect with Karuna Rawal

PwC's accounting and financial reporting podcast
Accounting for the cost of externally marketed software

PwC's accounting and financial reporting podcast

Play Episode Listen Later Aug 20, 2024 39:35


Text us your thoughts on this episodeWe kick off our miniseries on software costs. They are accounted for using two different models depending on whether the software is used internally or externally. In this episode we focus on the external use model applicable to software to be sold, leased, or otherwise marketed as a separate product or embedded within a product or process.In this episode, we discuss:3:20 – How to determine whether the internal use or externally-marketed software models apply 10:08 – An overview of the externally marketed software model (ASC 985-20)11:25 – When technological feasibility of software is established19:55 – The types of costs capitalized under the model for externally marketed software22:40 – Practical challenges in applying the externally marketed software model27:55 – Applying the guidance to Artificial Intelligence (AI) 31:10 – An update on the FASB's software costs projectFor more information, see chapter 2 of our Software costs guide. Additionally, follow this podcast on your favorite podcast app for more episodes. Mike Coleman is a partner in PwC's National Office who specializes in accounting for revenue and software arrangements and has served technology clients for much of his career. In addition, Mike has represented the firm on the AICPA Software Task Force.Pat Durbin is a Deputy Chief Accountant in PwC's National Office. He has over 30 years of experience consulting with our clients and engagement teams on complex accounting matters, including issues related to revenue, compensation, income taxes, and inventory under both US GAAP and IFRS.Heather Horn is the PwC National Office Sustainability & Thought Leader, responsible for developing our communications strategy and conveying firm positions on accounting, financial reporting, and sustainability matters. In addition, she is part of PwC's global sustainability leadership team, developing interpretive guidance and consulting with companies as they transition from voluntary to mandatory sustainability reporting. She is also the engaging host of PwC's quarterly webcast series.Transcripts available upon request for individuals who may need a disability-related accommodation. Please send requests to us_podcast@pwc.com. 

80's Flick Flashback
#114 - "Masters of the Universe" (1987) with Chris Adams, Gerry D, and Laramy Wells

80's Flick Flashback

Play Episode Listen Later Aug 9, 2024 84:47


Remember the days when action figures ruled our imaginations and epic battles between good and evil played out in our living rooms? Step into 1987, when a beloved toy line and animated series leaped onto the big screen in a live-action spectacle. In this 80s flick a intergalactic battle spills from the fantastical world of Eternia into our own. Marketed as the “Star Wars of the 80s, it didn't quite live up to the hype. But today it is remembered as a cult classic that brought our favorite toy characters to life in a whole new way. So jump through the travel portal, grab the Power Sword and shout, 'I have the power!' as Tim Williams and guest co-hosts, Chris Adams (from "Retro Life 4 You Podcast"), Gerry D (from "Totally Rad Christmas Podcast"), and Laramy Wells (from "Moving Panels Podcast") discuss “Masters of the Universe” from 1987 on this episode of the 80s Flick Flashback Podcast. Here are some additional behind-the-scenes trivia we were unable to cover on this episode: The Throne Room set of Castle Grayskull was originally two large adjoining sound stages. The wall between the sets was knocked down to make one gigantic sound stage. At that time, this was the largest set Hollywood had seen in over 40 years. Production designer William Stout intentionally wanted the interior of Castle Grayskull to combine elements of both good and evil. In an online interview, Stout explained, "This was the seat of power for the entire universe. I reasoned that power is neither good nor bad; it's what you make of it and how you use it. Above floor level were what I called the Space Gods—giant bronze statues of those who had used the power based in that room for good. Below floor level was the dark side—demonic creatures that represented power used for bad or evil." Many reviewers compared the movie to the cartoon, but it was based on the toys. The toys initially portrayed He-Man as a barbarian in the first mini-comics, not as Prince Adam or Orko. Ed Pressman was interested in the property before the cartoon aired and purchased the movie rights for the Mattel characters, not from Filmation. Sources: Wikipedia, IMDB, Rotten Tomatoes, Box Office Mojo https://www.cbr.com/heman-masters-of-the-universe-trivia-facts-1987-movie/ Some sections were composed by ChatGPT We'd love to hear your thoughts on our podcast! You can share your feedback with us via email or social media. Your opinions are incredibly valuable to us, and we'd be so grateful to know what you enjoyed about our show. If we missed anything or if you have any suggestions for 80s movies, we'd love to hear them too! If you're feeling extra supportive, you can even become a subscription member through "Buy Me A Coffee". For more details and other fun extensions of our podcast, check out this link. Thank you for your support! https://linktr.ee/80sFlickFlashback

TCBCast: An Unofficial Elvis Presley Fan Podcast
TCBCast Bonus - "Memphis" Box Set Impressions + Listener Feedback (feat. John Michael Heath of EAP Society)

TCBCast: An Unofficial Elvis Presley Fan Podcast

Play Episode Listen Later Aug 9, 2024 66:39


Justin is joined by John Michael Heath of EAP Society (youtube.com/EAPSociety) to give their first impressions of the new Sony Legacy box set, "Memphis" which released today, August 9, 2024.  Marketed as "a comprehensive collection" of 111 recordings of Elvis made in his adoptive hometown from his time at Sam Phillips's Sun Records through to Chips Moman's American Sound, the iconic Stax, live at the Mid-South Coliseum and at his home, Graceland, "Memphis" is said to contain "newly mixed versions of the select recordings, pure and without overdubs" overseen by award-winning engineer Matt Ross-Spang and producer Ernst Jorgensen.  Spoilers: there's good news for those who want to re-experience the 1973, 1974 and 1976 material in a different light than you may be familiar with, and a faithful collection of the Sun material... but this set's presentation of the 1969 American Sound music is a different story altogether. And that "pure and without overdubs" claim? Well, you'll hear. The guys also answer listener feedback on this episode, including several about a recent Song of the Week, but since this discussion ran long, Justin and John will be back later with a separate, full length episode for the main topic intended to supplement and compliment the "Memphis" set, focused on the history of the music industry in Memphis, how Elvis was influenced by it, and how he in turn helped reshape it. 

Roose366
Solo Leveling Sequel Webtoon Goes #1 With 2 Million Views in 24 Hours

Roose366

Play Episode Listen Later Aug 3, 2024 4:12


Following the massive success of Solo Leveling, which racked up over 14 billion views worldwide, its sequel series Solo Leveling: Ragnarok gets off to a strong, befitting start. Following its official release on Kakaopage, Solo Leveling: Ragnarok pulled a massive two million views in just its first 24 hours of release, with around 2.8 million views 30 hours after its launch. Rated 9.9/10, the series currently ranks #1 on Kakao's real-time ranking, refreshed hourly based on user responses like views and purchases. Marketed as a pre-release ahead of its regular serialization on Thursdays, the launch lived up to its massive expectations, dropping 13 chapters comprising over 2,500 pages. The first three chapters are available to read (in Korean), boasting the stellar art that helped to popularize the original Solo Leveling in the first place. In the first statement from creative duo JIN (art) and Dangdo (story), both of REDICE STUDIO, the pair said, "Please look forward to the interesting growth story of the characters including Sung Suho, as well as the action scenes that become more splendid with each episode." Podcast: https://open.spotify.com/show/5knAeTAYpIE0RuswBrKfVe? si=a713499c4f2a42a5 Instagram: https://www.instagram.com/roose366 Gaming Channel: https://www.youtube.com/@RooseJp

A Better HR Business
Episode 256 - How HR Directors Want (And Don't Want) To Be Marketed To (based on real data) - with Siân Harrington

A Better HR Business

Play Episode Listen Later Jul 19, 2024 41:00


Ever wondered how HR Directors want (and don't want) to be marketed to? Siân Harrington, Co-Founder of The People Space and Siân Harrington Media Consulting, reveals the findings in our newest episode on the A Better HR Business podcast. Based on a recent study with 100 HR Directors from well-known brands, we've uncovered crucial information that will reshape the way you approach and connect with HR decision-makers. In a wide-ranging discussion, Siân and I talked about: ✅ Effective Marketing: using a consultative, evidence-based approach over aggressive sales tactics. ✅ Building credibility through personalized, relevant communication and physical marketing materials. ✅ Best practices for engagement and long-term relationship building. ✅ Learning from 100 HR directors about PR pitches, data sharing, and decision-making. ✅ Recognizing and correcting common mistakes in outreach to HR directors. ✅And much more! You can find the podcast discussion on the Get More HR Clients website. You can also find the 'A Better HR Business' podcast on all the main podcast players, including Apple Podcasts and Spotify. Feel free to tag in or share the show with any friends who are busy growing an HR-related business (recruitment, employee engagement, diversity & inclusion, HR admin, etc). Websites: www.thepeoplespace.com and www.sianharrington.com. LinkedIn profile: www.linkedin.com/in/sian-harrington-thepeoplespace For show notes and to see details of our previous guests, check out the podcast page here: www.GetMoreHRClients.com/Podcast HR BUSINESS GROWTH RESOURCES Get the new book - Grow A Successful HR Business Your Way Automated Lead-Generation Machine - On-Demand Masterclass & Workbook HR Business ChatGPT/AI Prompts Pack - ChatGPT Prompts Pack HR Business Planner - On-Demand Masterclass & Workbook How To Make Better Lead Magnets To Attract More Sales Leads - On-Demand Masterclass & Workbook Beat Your HR Business Blocks Course - Online Course Start Your HR Business - Coaching program Grow Your HR Business - Coaching program Consulting Services For HR Software And Consulting Firms: Consulting Services. VISIT GET MORE HR CLIENTS Want more clients for your HR-related consultancy or HR Tech business? Visit the Get More HR Clients website for articles, newsletters, podcasts, videos, resources, and more.  

NeurologyLive Mind Moments
FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

NeurologyLive Mind Moments

Play Episode Listen Later Jul 9, 2024 11:16


Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of donanemab as a new treatment for adults with early symptomatic Alzheimer disease (AD). Marketed as Kisunla, donanemab's approval marks the third antiamyloid therapy to get FDA greenlight for early-stage AD, following the controversial approval of aducanumab (Aduhelm; Biogen) in 2021 and lecanemab (Leqembi; Eisai) in 2023. Donanemab, administered as a 350 mg/20 mL once-monthly injection for intravenous infusion, had its approval supported by the phase 3 TRAILBLAZER-ALZ-2 trial (NCT04437511), a large-scale, double-blind, placebo-controlled trial that featured 1736 patients with early-stage AD. Following the approval, NeurologyLive sat down with Joel Salinas, MD, MBA, a behavioral neurologist at NYU Langone and clinical assistant professor in the department of neurology at the NYU Grossman School of Medicine. Salinas, who also serves as the chief medical officer at Isaac Health, discussed the positive impacts of the approval, the importance of patient selection for the medication, and how clinicians should discuss its benefits and harms to patients. In addition, he commented on how approvals like donanemab continue to carry momentum in the AD field going forward.  For more of NeurologyLive's coverage of donanemab's approval, head here: FDA Approves Eli Lilly's Donanemab for Early Symptomatic Alzheimer Disease Episode Breakdown: 2:10 – Positive downstream impacts of donanemab's approval 4:20 – Considerations and caution with prescribing donanemab 6:05 – Salinas on patient-clinician conversations about AD treatments 8:00 – Closing remarks and continued progress in AD field Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Roxy's Ride & Inspire RAWcast - Mountain Bike & Mindset Podcast
Shred, Send it & Insane Stunts! Is Mountain Biking marketed realistically? #024

Roxy's Ride & Inspire RAWcast - Mountain Bike & Mindset Podcast

Play Episode Listen Later Jul 7, 2024 16:47


Does popular Mountain Bike Marketing distort expectations, decrease self-esteem & ruin trails? I certainly believe it does to some extent - especially for adult riders new to the sport. In this episode I share my doubts and my thoughts about what really matters for most mountain bikers, what truly makes an expert rider and I appeal to the marketing experts of the huge brands.  Here's the Reel I mention in this podcast episode: https://www.instagram.com/roxybike_coaching/reel/C86l80hstvS/  Here's my Body Position Breakdown: https://youtu.be/SydGB5NN3Zg Work with me personally with my Signature 4-C-Formula for less fear and more fun on trails: https://roxybike.podia.com Support my work

Living Well with Robin Stoloff
Unveiling the Truth About New Weight Loss Meds: Benefits, Risks, and Proper Use

Living Well with Robin Stoloff

Play Episode Listen Later Jul 7, 2024 11:17 Transcription Available


Marketed under brand names such as Ozempic, Wegovy, and Mounjaro, these weight loss and diabetes medications are exploding in popularity.  So what are the benefits? What are the risks? Endocrinologist Dr. Samar Bursheh breaks it all down in this episode. She is the owner and medical director of Nutriamed Metabolic Lifestyle Center in Egg Harbor Township, New Jersey. Originally developed for type 2 diabetes, these medications are now also approved for weight loss. However, they are not a quick fix. Dr. Bursheh emphasizes the importance of proper medical supervision, lifestyle changes, and individualized care. She discusses who should and shouldn't take these medications, potential side effects, and the ultimate goal of achieving long-term health without medication. Join us as we explore the transformative potential of these drugs, the importance of medical guidance, and the holistic approach taken at Nutriamed. Learn how combining medication with proper nutrition, exercise, and support can lead to sustainable weight loss and improved overall health. For more information or to contact Dr. Bursheh, visit nutriamed.com or call 609-415-2888. 

For Advisors By Advisors
For Advisor By Advisors - Interview with Paul G. McManus, Book Author, and Founder of MCMF Publishing - Does Writing Books Help Financial Advisors Gain Clients? Only if Marketed Correctly!

For Advisors By Advisors

Play Episode Listen Later Jul 3, 2024 23:27


In this episode, we speak with Paul G. McManus, Book Author, and Founder of MCMF Publishing.  We went over how books can be a marketing concept that financial advisors should consider.  Also, how to use the book to market to the segment you want to attract.  We also spent some time going over how to use LinkedIn effectivity to market yourself and get more business.  I hope you enjoy it! Did this podcast get you to take action in some way? I'd love your thoughts and feedback on this podcast.  I'm always looking to connect with like-minded creative people that are motivated and want to be better!  You can connect to me on LinkedIn at https://www.linkedin.com/in/evanmayer/or feel free to email me at foradvisorsbyadvisors@gmail.com. Follow us on Instagram! @ForAdvisorsByAdvisors and YouTube For Advisors By Advisors

Diabetes Connections with Stacey Simms Type 1 Diabetes
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Jun 21, 2024 7:59


It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CGM at the Olympcs and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Quick note – the American Diabetes Association Scientific Sessions is this weekend. That means new research studies will be released, technology announced, and likely lots of news will be made. I'm recording this before the conference starts – if there's enough going on we may have an additional In the News next week. XX Our top story right now… XX No more insulin pens for South Africa.. .as the pharmaceutical industry shifts production priorities to blockbuster weight-loss drugs. Novo Nordisk, the company that has supplied South Africa with human insulin in pens for a decade, opted not to renew its contract, which expired last month. No other company has bid on the contract — to supply 14 million pens for the next three years, at about $2 per pen. Novo Nordisk's  drugs Ozempic and Wegovy, which are widely prescribed in the U.S. for weight loss, are sold in single-use pens produced by many of the same contracted manufacturers who make the multidose insulin pens. A month's supply of Ozempic in the United States costs about $1,000, far more than insulin. Novo Nordisk dominates the global market for insulin in pens and has supplied South Africa since 2014. Eli Lilly, the other major producer, has indicated in recent months that it is struggling to keep up with the significant demand for its weight-loss drug Zepbound. Novo Nordisk is continuing to supply human insulin in vials to South Africa, where more than four million people live with diabetes, but pens are considered much easier to use and more precise. The vial system was phased out for most South Africans in 2014. But recently, South Africa's National Department of Health instructed clinicians that they should teach patients how to use vials and syringes of insulin instead of pens. I posted about this already and said this is a canary in the coal mine and everyone going to ADA should be asking Novo and Lilly about this. GLP medications are fantastic but insulin cannot be left behind. https://www.nytimes.com/2024/06/19/health/insulin-pens-south-africa-ozempic-wegovy.html XX Once a week basal insulin – for type 1 and type 2 – comes to Canada. Novo Nordisk announced that it's version of insulin icodec will be available starting June 30th. They are calling it.. Awiqli – I promise I didn't make that up.  Canada is the first country to get the product. Awiqli works as a time release of insulin over the course of a week. It is more expensive. And  Canada's Drug Agency, which assesses drugs and recommends whether they should qualify for reimbursement under public drug plans, is still doing the math here. No word on private insurers coverage yet. An FDA advisory board recently passed on approving weekly basal for people with type 1, saying the risk of low blood sugar was too great. But the full FDA hasn't yet weighed in.   https://www.ctvnews.ca/health/world-s-first-weekly-insulin-injection-coming-to-canada-in-2-weeks-manufacturer-says-1.6929321 XX The prevalence of people over 65 living with type 1 diabetes  went up 180% in the past 30 years, a new study finds. That's an increase of 1.3 million people over 65 in 1990 with the disease to 3.7 million in 2019, the authors noted in a study published on June 12 in The BMJ. Data included people from 204 countries and territories from 1990 to 2019. Dying from type 1 diabetes slipped by about 1% every year since 1990, the data also showed. The mortality for people 65 and up went down by 25% during the three decades covered in the study. The most rapid prevalence was in North Africa and the Middle East, and Western Europe, and the slowest increase in prevalence was in North America. All 21 regions around the world had an increased prevalence of type 1 diabetes in people over 65. The disease no longer contributes to a reduced life expectancy for many people due to medical care improvements, say these researchers. https://www.mcknights.com/news/report-type-1-diabetes-prevalence-in-older-adults-nearly-triples-since-1990s/ XX Hearing more about the limited rollout of Omnipod 5 with the Dexcom G7. This was announced in February but just seems to really be getting underway. A few people have received emails that people new to the system will be getting this first.. but that at the end of July current users will get a controller update so they can use G7 with the current pods. We'll have more on this soon – I don't have a link for you - but thanks to all of you who sent me those emails very much appreciate it. XX New life possible for Korean insulin pump EOPatch– this is a competitor to the Omnipod. A court has killed an injunction that meant the company, EOFlow, could not bring the patch pump to the US. Last year, the court initially granted that injunction and Medtronic backed out of an acquisition plan. No word yet from Medtronic if that deal is back on.. or if another company may work to bring EOFlow to the US. https://news.bloomberglaw.com/business-and-practice/ban-against-insulin-pump-patch-sales-reversed-by-federal-circuit XX The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. This is a mechanical patch pump that replaces fast-acting injections. This is an extension from 3 days to four.. now each patch replaces up to 12 injections making it the longest wearable insulin delivery patch. The company says that can be 1000 fewer shots a year. Marketed mostly to people with type 2 diabetes who use insulin, the company says nearly 90% of patients using CeQur Simplicity reported following their insulin regimen better as compared to multiple daily injections.(4) The patch is clinically proven to improve glycemic control, with patients achieving significantly improved A1C and time-in-range (TIR) goals.(5,6) https://www.prweb.com/releases/cequr-simplicity-a-wearable-mealtime-insulin-delivery-device-obtains-fda-clearance-for-4-days-of-wear-to-further-simplify-diabetes-management-302173938.html XX A warning from Roche which says “dangerous counterfeits” of its diabetes medical devices ended up for sale on Amazon. Roche accused manufacturers and sellers based in India of selling counterfeit versions of test strips for its Accu-Chek glucometers.  This is part of a federal lawsuit. Roche said the counterfeit test strips are expired or nearly expired products that are repackaged with counterfeit labels bearing Roche's registered U.S. trademarks and fake expiration dates. After the suit was filed, a judge granted Roche's request for a temporary restraining order to stop the defendants from selling the counterfeit products. The Amazon stores that were offering the products for sale appear to have been taken down. Amazon is not a defendant in the case, but Roche claims that as part of the alleged scheme all of the counterfeit products sent to the U.S. were stored at Amazon warehouses across the country, including in Brooklyn. https://www.cnbc.com/2024/06/10/roche-counterfeit-diabetes-medical-devices.html XX Edgepark Commercial XX Summer Olympics this year may be a showcase for CGMs. Abbott is sponsoring a Dutch long distance running, he'll be wearing the Libre. Other athletes are using the CGMs in training and may wear as allowed in their sports. There isn't a lot of proof yet that these devices make a big difference for people without diabetes.. but high level athletes are looking for any edge possible. Expect to hear a lot more about this in the lead up to the Olympics July 26th. https://learningenglish.voanews.com/a/olympic-athletes-turn-to-diabetes-technology-in-medal-chase/7653234.html XX Join us again soon!

The Crochet Authority
Ep 22: Everything Wrong With Esty

The Crochet Authority

Play Episode Listen Later Jun 12, 2024 64:57


Welcome to ep 22 of The Crochet Authority pod!! Today we are chatting about the online marketplace, Etsy. Marketed as a place for artists to sell their goods to a larger audience, it seems like the best place to buy and sell your handmade or vintage goods. But the platform has changed a lot in recent years, largely for the worse. We dive deep into all things Etsy, and how we feel about a platform we should all be loving.

The Tory Lowe Show
6/12/24 1PM: Marketed Thoughts

The Tory Lowe Show

Play Episode Listen Later Jun 12, 2024 48:14


6/12/24 1PM: Marketed Thoughts full 2894 Wed, 12 Jun 2024 21:13:52 +0000 dC1zUdN3HhxHMh6LWgTxCN7MjZGd9Ngf The Tory Lowe Show society & culture 6/12/24 1PM: Marketed Thoughts Tory Lowe is a community advocate committed to making a difference. Catch up on the latest with Tory on The Tory Lowe Show, which airs weekdays from 1p-4p on 101.7 The Truth. 2021, Good Karma Brands, LLC

All Things Boobs Podcast
Lingerie models talk advertising | How bras are marketed

All Things Boobs Podcast

Play Episode Listen Later May 17, 2024 7:24


Have you ever wondered what goes on behind the scenes of lingerie shoots? This week we discuss the bra industry from the perspective of models who have worked with several brands to help advertise products. We also discuss the complex nature of balancing the function of the bra with the right fit models with selling a "message" of the brand - be it looking and feeling sexy to empowerment to proper supportFollow us on IG! All Things Boobs: https://www.instagram.com/allthingsboobs_podcast/ Saterra: https://www.instagram.com/fullerbustbestie/ Madison: https://www.instagram.com/madisonxalexandra/ The +4 method is OUT! Ladies, we have been doing it wrong for far too long, and it's time you know how a bra should fit correctly and the signs to know if it doesn't! A Bra That Fits Calculator: https://www.abrathatfits.org/calculator.php (https://www.abrathatfits.org/calculator.php) If you still don't know your true bra size or you haven't been fit in a while, please don't hesitate to book a virtual fitting with Saterra: https://calendly.com/fullerbustbestie/30min Listen to us on Spotify: https://open.spotify.com/show/1kBPxklSqQyL4e6zhvttP1 Work with us: allthingboobs@outlook.com Subscribe to Saterra on YouTube: https://www.youtube.com/@Fullerbustbestie/featured Visit Saterra's Website: https://www.fullerbustbestie.com Follow Madison on TikTok: https://www.tiktok.com/@madisonxalexandra?_t=8iCuSLqcUc4&_r=1 Virtual fittings (via photos | 20 British pounds) with Rosie (@bellarosalingerie) - https://www.bellarosalingerie.co.uk/plans-pricing (https://www.bellarosalingerie.co.uk/plans-pricing) - Special note: Rosie is a private fitter located in the UK but can fit by eye over photos! You can then order through her catalogue for her to ship worldwide! She caters to 26-60 bands and up to M Cup UK (S cup US) Virtual fittings (via zoom | Free ) with Bravissimo (@lovebravissimo) - https://www.bravissimo.com/us/virtual-fitting/?utm_source=referral+&utm_medium=madisonalexandra&utm_campaign=fittings&utm_id=tiktoksummer - Special note: Bravissimo is a retailer that carries its own styles as well as styles from other brands. They specialize in 28-40 bands and in D-L Cups UK (D-Q cups US)

The Gabby Reece Show
#266 How You're Being Marketed To Is Changing Dramatically

The Gabby Reece Show

Play Episode Listen Later May 13, 2024 82:25


In this episode, I explore the fascinating world of automotive marketing with Allyson Witherspoon, the Chief Marketing Officer of Nissan. From Tokyo, Japan, Allyson shares her insights on the evolution of car buying, the role of technology in marketing, and the global challenges of steering a renowned brand through the dynamic landscapes of consumer needs and digital transformation. Sponsors: ritual.com/GABBY for 25% off ThriveMarket.com/gabby for 30% off your first order, plus a FREE $60 gift!  Vionicshoes.com and use code GABBY at checkout for 15% off your entire order when you log into your account  OneSkin - Get 15% with code REECE at Oneskin.co Main Sections & Timecodes: Navigating Global Marketing Challenges [00:00:00 - 00:10:00] Allyson and Gabby discuss the complexities of marketing in a global landscape and how consumer empowerment has changed the industry. The Impact of Technology on Automotive Sales [00:10:01 - 00:20:00] Deep dive into how digital advancements have revolutionized the way consumers research, purchase, and interact with automotive brands. Leadership and Life Balance [00:20:01 - 00:30:00] Allyson talks about her daily routines and management style, emphasizing the importance of personal well-being for effective leadership. Cultural Nuances in Business [00:30:01 - 00:40:00] Discussion on adapting to different cultural expectations and business practices, with a focus on Allyson's experiences in Japan compared to the U.S. Future of Driving: Autonomous Vehicles [00:40:01 - 00:50:00] Insights into the development of self-driving cars and the potential impact on future mobility. Marketing Innovations and Consumer Engagement [00:50:01 - End] Exploration of new marketing strategies and the importance of engaging with consumers through innovative approaches in a competitive landscape. Everything Gabby Reece: Instagram: https://www.instagram.com/gabbyreece/ TikTok: https://www.tiktok.com/@gabbyreeceofficial Facebook: https://www.facebook.com/OfficialGabrielleReece/ Gabby Reece Website - https://gabriellereece.com/ Gabby Reece Show Transcript: https://gabriellereece.com/podcast/ The Gabby Reece Show Podcast on Youtube: https://www.youtube.com/channel/UCeEINLNlGvIceFOP7aAZk5A Bio: Gabrielle 'Gabby' Reece is an American actress, podcaster, and former model and professional volleyball player best known for hosting a lifestyle, health & fitness podcast titled The Gabby Reece Show. Additionally, she is the co-founder of XPT | Extreme Performance Training and Laird Superfood alongside her husband and big wave surfer Laird Hamilton. The Gabby Reece Show talks to top experts with the goal of extracting the best information you will need to navigate the universe of health, fitness, relationships, parenting, and business. Gabby keeps it simple but gets to the heart of the conversation with the hopes of providing you with realistic takeaways. Thank you for tuning into "The Gabby Reece Show." If you found this information helpful, consider sharing this episode with someone who needs it. And subscribe to make sure you never miss informative conversations like this. Learn more about your ad choices. Visit megaphone.fm/adchoices

Chick Lit Book Club Podcast
Episode 87: Love You, Mean It by Jilly Gagnon

Chick Lit Book Club Podcast

Play Episode Listen Later Apr 3, 2024 121:35


Welcome lovely listeners! Today, we're discussing Love You, Mean It by Jilly Gagnon. We got an ARC through NetGalley and we're covering it early for scheduling reasons. Marketed as a playful romantic comedy featuring dueling delis, fake dating, a shockingly awesome ex, and juuuuuust the right amount of amnesia. Having read the book, we can confirm that it's the perfect amount of amnesia. Also discussed: Cameo as a concept (Thank you Thoren Bradley for the birthday wishes!), documentaries that make you think, and the Ghostbusters empire. Up Next: Risks and Whiskey by Dani McLean What We're Reading: Bunny by Layla Fae Wedded to the Broken Duke by Ava McAdams The Midnight Voyeur - E.L. Koslo What We're Listening To: Modern Family The Truth vs Alex Jones SHOW INFORMATION: Follow us on Spotify! (It helps us with sponsors!) Patreon: Support Us Here Website: www.chicklitbookclubpodcast.com Merch: https://chicklitbookclubpodcast.threadless.com/ Instagram and Threads: ChickLitBookClubPodcast TikTok: ChickLitBookClub Pinterest: ChickLitBookClubPodcast BlueSky:@clbcpodcast.bsky.social Youtube: @ChickLitBookClub Email: chicklitbookclubpodcast@gmail.com

Hard Factor
New $2B Luxury Submarine Marketed to Secretive Evil Billionaires | 2.15.24

Hard Factor

Play Episode Listen Later Feb 15, 2024 38:53


On Episode 1399 the boys dive into the sexual and terrifying world of personal luxury submarines, and MUCH more… Timestamps: (00:00:00) Teasers! (00:03:11) Best presidents of all-time live stream and Trivia night coming up! GET READY! (00:04:32) Driver in fatal Amish buggy crash charged, tried to have identical twin sister take the fall, Sheriff says (00:16:52) US District Judge dismisses the majority of copyright infringement cases against OpenAI's ChatGPT brought forth by Sarah Silverman And Other Authors (00:25:02) Chiefs parade shooting: 1 confirmed dead, 3 detained, 22 gunshot victims per Kansas City police (00:26:52) House Intelligence Committee: China and Russia's hypersonic missiles threaten US national security (00:29:33) Migaloo aims to disrupt superyacht market with giant $2 billion customizable luxury submarine (00:38:35) Join us on Patreon for more Hard Factor! - patreon.com/hardfactor Brought to you by Squarespace - Head to https://www.squarespace.com/HARDFACTOR to save 10% off your first purchase of a website or domain using code (HARDFACTOR). Brought to you by Robinhood - Robinhood Gold gets you the most for your retirement thanks to their IRA with a 3% match. This offer is good through April 30. Get started at Robinhood.com/boost. Subscription fees apply

Boys' Bible Study
Have You Been Left Behind? (VHS, 1999) TEASER

Boys' Bible Study

Play Episode Listen Later Feb 4, 2024 3:43


Subscribe today for access to our full catalog of bonus episodes, including 2+ new episodes every month! www.patreon.com/boysbiblestudy If you're reading this, the worst has happened. All of your friends and family who are much better than you have been raptured, yet you're stuck here alone on earth. If you look out the window right now, it's highly likely you'll observe thermonuclear war. It's never been more over for you… or is it? A transmission from the LEFT BEHIND cinematic universe might be just the kick you need to get you inspired to make the most of your life post-rapture. Marketed as a piece of genuine found footage from a church group, HAVE YOU BEEN LEFT BEHIND? sells itself as a VHS tape providing life advice for those “left behind”, but it's actually a cleverly staged y2k era viral marketing stunt for the LEFT BEHIND series of books and films. On the tape, a Pastor Vernon Billings warmly greets the viewer, telling them they have another chance to find salvation in this life — but eagle-eared LEFT BEHIND fans might recognize this pastor as a minor character from the series. The VHS tape jacket and contents leave some hints to this connection, but this interesting artifact of Christian ARG marketing has still fooled a lot of people over the years into believing it's genuine. The Bible Boys discuss the tape's take on rapture theology and also take time to investigate LEFT BEHIND: ETERNAL FORCES, the now-defunct Christian real-time strategy PC game also based on the famous series. View our full episode list and subscribe to any of our public feeds: http://boysbiblestudy.com Unlock 2+ bonus episodes per month: http://patreon.com/boysbiblestudy Subscribe to our Twitch for monthly streams: http://twitch.tv/boysbiblestudy Follow us on Instagram: http://instagram.com/boysbiblestudy Follow us on Twitter: http://twitter.com/boysbiblestudy

Free Agent Lifestyle
How LOVE Is Marketed To Men, Yet It Is UNSUSTAINABLE | Jason Momoa Divorced?

Free Agent Lifestyle

Play Episode Listen Later Jan 9, 2024 172:53


How LOVE Is Marketed To Men, Yet It Is UNSUSTAINABLE | Jason Momoa Divorced? Coach Greg Adams YouTube Channel Free Agent Lifestyle YouTube Channel

JAMA Clinical Reviews: Interviews about ideas & innovations in medicine, science & clinical practice. Listen & earn CME credi

Obesity affects approximately 42% of adults in the US. Multiple strategies are available to treat obesity, including behavior therapies, GLP-1 receptor agonists, and bariatric surgery. Therapies vary in effectiveness and risks. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses evidence-based obesity treatment with Melanie Jay, MD, MS, New York University Grossman School of Medicine. Related Content: Obesity Management in Adults As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management